Project
Mucociliary differentiation, bronchial epithelial cells, human (Ross 2007)
Navigation
Downloads
Results for BATF
Z-value: 2.20
Motif logo
Transcription factors associated with BATF
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
BATF
|
ENSG00000156127.8 | BATF |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| BATF | hg38_v1_chr14_+_75522427_75522483 | -0.49 | 6.1e-03 | Click! |
Activity profile of BATF motif
Sorted Z-values of BATF motif
Network of associatons between targets according to the STRING database.
First level regulatory network of BATF
| Promoter | Score | Transcript | Gene | Gene Info |
|---|---|---|---|---|
| chr1_-_153460644 | 14.27 |
ENST00000368723.4
|
S100A7
|
S100 calcium binding protein A7 |
| chr1_+_150508099 | 14.23 |
ENST00000346569.6
ENST00000369047.9 |
ECM1
|
extracellular matrix protein 1 |
| chr19_-_50983815 | 14.08 |
ENST00000391807.5
ENST00000593904.1 ENST00000595820.6 |
KLK7
|
kallikrein related peptidase 7 |
| chr9_+_33795551 | 12.70 |
ENST00000379405.4
|
PRSS3
|
serine protease 3 |
| chr18_+_23873000 | 12.29 |
ENST00000269217.11
ENST00000587184.5 |
LAMA3
|
laminin subunit alpha 3 |
| chr19_-_51001138 | 11.80 |
ENST00000593490.1
|
KLK8
|
kallikrein related peptidase 8 |
| chr1_-_153549120 | 11.10 |
ENST00000368712.1
|
S100A3
|
S100 calcium binding protein A3 |
| chr1_+_150508074 | 10.37 |
ENST00000369049.8
|
ECM1
|
extracellular matrix protein 1 |
| chr1_-_153057504 | 9.67 |
ENST00000392653.3
|
SPRR2A
|
small proline rich protein 2A |
| chr7_+_48088596 | 9.23 |
ENST00000416681.5
ENST00000331803.8 ENST00000432131.5 |
UPP1
|
uridine phosphorylase 1 |
| chr1_-_153094521 | 9.05 |
ENST00000368750.8
|
SPRR2E
|
small proline rich protein 2E |
| chr2_-_112836702 | 8.62 |
ENST00000416750.1
ENST00000263341.7 ENST00000418817.5 |
IL1B
|
interleukin 1 beta |
| chr1_-_153549238 | 8.40 |
ENST00000368713.8
|
S100A3
|
S100 calcium binding protein A3 |
| chr15_-_74212219 | 8.14 |
ENST00000449139.6
|
STRA6
|
signaling receptor and transporter of retinol STRA6 |
| chr12_+_8822610 | 8.09 |
ENST00000299698.12
|
A2ML1
|
alpha-2-macroglobulin like 1 |
| chr19_-_35528221 | 8.01 |
ENST00000588674.5
ENST00000452271.7 ENST00000518157.1 |
SBSN
|
suprabasin |
| chr15_-_79971164 | 7.95 |
ENST00000335661.6
ENST00000267953.4 ENST00000677151.1 |
BCL2A1
|
BCL2 related protein A1 |
| chr1_-_153375591 | 7.93 |
ENST00000368737.5
|
S100A12
|
S100 calcium binding protein A12 |
| chr15_-_74212256 | 7.84 |
ENST00000416286.7
|
STRA6
|
signaling receptor and transporter of retinol STRA6 |
| chr12_+_13196718 | 7.58 |
ENST00000431267.2
ENST00000542474.5 ENST00000544053.5 ENST00000256951.10 |
EMP1
|
epithelial membrane protein 1 |
| chr1_-_153113507 | 6.80 |
ENST00000468739.2
|
SPRR2F
|
small proline rich protein 2F |
| chr7_+_142760398 | 6.72 |
ENST00000632998.1
|
PRSS2
|
serine protease 2 |
| chr11_-_124445696 | 6.61 |
ENST00000642064.1
|
OR8B8
|
olfactory receptor family 8 subfamily B member 8 |
| chr6_+_73696145 | 6.28 |
ENST00000287097.6
|
CD109
|
CD109 molecule |
| chr2_-_112784486 | 6.26 |
ENST00000263339.4
|
IL1A
|
interleukin 1 alpha |
| chr1_-_153070840 | 6.15 |
ENST00000368755.2
|
SPRR2B
|
small proline rich protein 2B |
| chr22_+_31092447 | 6.10 |
ENST00000455608.5
|
SMTN
|
smoothelin |
| chr17_-_41612757 | 6.02 |
ENST00000301653.9
ENST00000593067.1 |
KRT16
|
keratin 16 |
| chr7_+_142770960 | 5.79 |
ENST00000632805.1
ENST00000633969.1 ENST00000539842.6 |
PRSS2
|
serine protease 2 |
| chr6_-_131000722 | 5.55 |
ENST00000528282.5
|
EPB41L2
|
erythrocyte membrane protein band 4.1 like 2 |
| chr11_-_102798148 | 5.48 |
ENST00000315274.7
|
MMP1
|
matrix metallopeptidase 1 |
| chr18_+_63775395 | 5.41 |
ENST00000398019.7
|
SERPINB7
|
serpin family B member 7 |
| chr18_+_63775369 | 5.27 |
ENST00000540675.5
|
SERPINB7
|
serpin family B member 7 |
| chr5_+_136059151 | 5.26 |
ENST00000503087.1
|
TGFBI
|
transforming growth factor beta induced |
| chr11_+_69294107 | 5.26 |
ENST00000441339.3
ENST00000308946.3 ENST00000535407.1 |
MYEOV
|
myeloma overexpressed |
| chr12_-_94616061 | 5.24 |
ENST00000551457.1
|
TMCC3
|
transmembrane and coiled-coil domain family 3 |
| chr15_-_74209019 | 4.99 |
ENST00000323940.9
|
STRA6
|
signaling receptor and transporter of retinol STRA6 |
| chr19_-_43780957 | 4.97 |
ENST00000648319.1
|
KCNN4
|
potassium calcium-activated channel subfamily N member 4 |
| chr14_+_23630109 | 4.88 |
ENST00000432832.6
|
DHRS2
|
dehydrogenase/reductase 2 |
| chr21_+_39657310 | 4.77 |
ENST00000380618.5
|
B3GALT5
|
beta-1,3-galactosyltransferase 5 |
| chr12_-_52452139 | 4.77 |
ENST00000252252.4
|
KRT6B
|
keratin 6B |
| chr2_+_113117889 | 4.73 |
ENST00000361779.7
ENST00000259206.9 ENST00000354115.6 |
IL1RN
|
interleukin 1 receptor antagonist |
| chr3_+_172754457 | 4.61 |
ENST00000441497.6
|
ECT2
|
epithelial cell transforming 2 |
| chr7_-_24757926 | 4.60 |
ENST00000342947.9
ENST00000419307.6 |
GSDME
|
gasdermin E |
| chr5_+_160421847 | 4.59 |
ENST00000352433.10
ENST00000517480.1 ENST00000520452.5 ENST00000393964.1 |
PTTG1
|
PTTG1 regulator of sister chromatid separation, securin |
| chrX_+_136169624 | 4.56 |
ENST00000394153.6
|
FHL1
|
four and a half LIM domains 1 |
| chr8_+_7894674 | 4.53 |
ENST00000302247.3
|
DEFB4A
|
defensin beta 4A |
| chr9_+_33750669 | 4.48 |
ENST00000361005.10
ENST00000342836.9 ENST00000429677.8 |
PRSS3
|
serine protease 3 |
| chr17_+_76385256 | 4.46 |
ENST00000392496.3
|
SPHK1
|
sphingosine kinase 1 |
| chr2_-_31217511 | 4.41 |
ENST00000403897.4
|
CAPN14
|
calpain 14 |
| chr12_-_95116967 | 4.39 |
ENST00000551521.5
|
FGD6
|
FYVE, RhoGEF and PH domain containing 6 |
| chr19_-_43198079 | 4.25 |
ENST00000597374.5
ENST00000599371.1 |
PSG4
|
pregnancy specific beta-1-glycoprotein 4 |
| chr8_-_7416863 | 4.23 |
ENST00000318157.3
|
DEFB4B
|
defensin beta 4B |
| chr19_+_44671452 | 4.21 |
ENST00000358777.9
|
CEACAM19
|
CEA cell adhesion molecule 19 |
| chr19_-_42528380 | 4.19 |
ENST00000403461.5
ENST00000352591.9 ENST00000358394.7 ENST00000403444.7 ENST00000161559.11 ENST00000599389.1 |
CEACAM1
|
CEA cell adhesion molecule 1 |
| chr9_+_72577939 | 4.18 |
ENST00000645773.1
|
TMC1
|
transmembrane channel like 1 |
| chr11_-_82997477 | 4.12 |
ENST00000534301.5
|
RAB30
|
RAB30, member RAS oncogene family |
| chr8_-_27838034 | 4.11 |
ENST00000522944.5
|
PBK
|
PDZ binding kinase |
| chr10_+_17228215 | 4.11 |
ENST00000544301.7
|
VIM
|
vimentin |
| chr11_-_125592448 | 4.08 |
ENST00000648911.1
|
FEZ1
|
fasciculation and elongation protein zeta 1 |
| chr19_+_6531018 | 4.06 |
ENST00000245817.5
|
TNFSF9
|
TNF superfamily member 9 |
| chr15_+_69414304 | 4.03 |
ENST00000352331.8
ENST00000679126.1 ENST00000647715.1 ENST00000559279.6 |
KIF23
|
kinesin family member 23 |
| chr8_+_10672623 | 4.01 |
ENST00000304519.10
|
C8orf74
|
chromosome 8 open reading frame 74 |
| chr1_+_153416517 | 3.99 |
ENST00000368729.9
|
S100A7A
|
S100 calcium binding protein A7A |
| chr1_-_112935984 | 3.95 |
ENST00000443580.6
|
SLC16A1
|
solute carrier family 16 member 1 |
| chr7_-_23347704 | 3.94 |
ENST00000619562.4
|
IGF2BP3
|
insulin like growth factor 2 mRNA binding protein 3 |
| chr12_-_121800558 | 3.91 |
ENST00000546227.5
|
RHOF
|
ras homolog family member F, filopodia associated |
| chr12_+_53098846 | 3.90 |
ENST00000650247.1
ENST00000549628.1 |
IGFBP6
|
insulin like growth factor binding protein 6 |
| chr13_+_77535681 | 3.89 |
ENST00000349847.4
|
SCEL
|
sciellin |
| chr13_+_77535742 | 3.86 |
ENST00000377246.7
|
SCEL
|
sciellin |
| chr11_-_65900375 | 3.86 |
ENST00000312562.7
|
FOSL1
|
FOS like 1, AP-1 transcription factor subunit |
| chr7_+_142749465 | 3.85 |
ENST00000486171.5
ENST00000619214.4 ENST00000311737.12 |
PRSS1
|
serine protease 1 |
| chr13_+_77535669 | 3.84 |
ENST00000535157.5
|
SCEL
|
sciellin |
| chr17_-_7590072 | 3.77 |
ENST00000538513.6
ENST00000570788.1 ENST00000250055.3 |
SOX15
|
SRY-box transcription factor 15 |
| chr9_-_136996555 | 3.76 |
ENST00000494426.2
|
CLIC3
|
chloride intracellular channel 3 |
| chr19_-_51065067 | 3.75 |
ENST00000595547.5
ENST00000335422.3 ENST00000595793.6 ENST00000596955.1 |
KLK13
|
kallikrein related peptidase 13 |
| chr1_+_17205119 | 3.72 |
ENST00000375471.5
|
PADI1
|
peptidyl arginine deiminase 1 |
| chr13_-_30306997 | 3.71 |
ENST00000380617.7
ENST00000441394.1 |
KATNAL1
|
katanin catalytic subunit A1 like 1 |
| chr22_-_37188281 | 3.67 |
ENST00000397110.6
|
C1QTNF6
|
C1q and TNF related 6 |
| chr13_-_60013178 | 3.66 |
ENST00000498416.2
ENST00000465066.5 |
DIAPH3
|
diaphanous related formin 3 |
| chr15_+_69414246 | 3.66 |
ENST00000260363.9
ENST00000395392.6 |
KIF23
|
kinesin family member 23 |
| chrX_+_136169664 | 3.65 |
ENST00000456445.5
|
FHL1
|
four and a half LIM domains 1 |
| chr15_-_70702273 | 3.65 |
ENST00000558758.5
ENST00000379983.6 ENST00000560441.5 |
UACA
|
uveal autoantigen with coiled-coil domains and ankyrin repeats |
| chr19_+_44671722 | 3.62 |
ENST00000403660.3
|
CEACAM19
|
CEA cell adhesion molecule 19 |
| chr21_-_26843012 | 3.60 |
ENST00000517777.6
|
ADAMTS1
|
ADAM metallopeptidase with thrombospondin type 1 motif 1 |
| chr19_-_18938982 | 3.58 |
ENST00000594439.5
ENST00000221222.15 |
HOMER3
|
homer scaffold protein 3 |
| chr11_-_62556230 | 3.56 |
ENST00000530285.5
|
AHNAK
|
AHNAK nucleoprotein |
| chr12_-_119804298 | 3.53 |
ENST00000678652.1
ENST00000678494.1 |
CIT
|
citron rho-interacting serine/threonine kinase |
| chr4_-_39032922 | 3.53 |
ENST00000344606.6
|
TMEM156
|
transmembrane protein 156 |
| chr1_-_16980607 | 3.50 |
ENST00000375535.4
|
MFAP2
|
microfibril associated protein 2 |
| chr4_-_80073465 | 3.49 |
ENST00000404191.5
|
ANTXR2
|
ANTXR cell adhesion molecule 2 |
| chr7_+_48089257 | 3.47 |
ENST00000436673.5
ENST00000395564.9 |
UPP1
|
uridine phosphorylase 1 |
| chr21_-_26843063 | 3.44 |
ENST00000678221.1
|
ADAMTS1
|
ADAM metallopeptidase with thrombospondin type 1 motif 1 |
| chr11_+_5596627 | 3.44 |
ENST00000380097.8
|
TRIM6
|
tripartite motif containing 6 |
| chr18_+_63777773 | 3.40 |
ENST00000447428.5
ENST00000546027.5 |
SERPINB7
|
serpin family B member 7 |
| chr16_-_46621345 | 3.39 |
ENST00000303383.8
|
SHCBP1
|
SHC binding and spindle associated 1 |
| chr11_-_65900413 | 3.33 |
ENST00000448083.6
ENST00000531493.5 ENST00000532401.1 |
FOSL1
|
FOS like 1, AP-1 transcription factor subunit |
| chr14_+_20469399 | 3.31 |
ENST00000361505.10
ENST00000553591.1 |
PNP
|
purine nucleoside phosphorylase |
| chr14_+_56117702 | 3.30 |
ENST00000559044.5
|
PELI2
|
pellino E3 ubiquitin protein ligase family member 2 |
| chr4_-_39032343 | 3.29 |
ENST00000381938.4
|
TMEM156
|
transmembrane protein 156 |
| chr1_+_183186238 | 3.29 |
ENST00000493293.5
ENST00000264144.5 |
LAMC2
|
laminin subunit gamma 2 |
| chr2_+_10122315 | 3.29 |
ENST00000360566.6
|
RRM2
|
ribonucleotide reductase regulatory subunit M2 |
| chr7_+_150991087 | 3.27 |
ENST00000461406.5
|
NOS3
|
nitric oxide synthase 3 |
| chr12_-_30735014 | 3.27 |
ENST00000433722.6
|
CAPRIN2
|
caprin family member 2 |
| chr2_-_89010515 | 3.25 |
ENST00000493819.1
|
IGKV1-9
|
immunoglobulin kappa variable 1-9 |
| chr9_+_72616266 | 3.14 |
ENST00000340019.4
|
TMC1
|
transmembrane channel like 1 |
| chr17_-_78874038 | 3.13 |
ENST00000586057.5
|
TIMP2
|
TIMP metallopeptidase inhibitor 2 |
| chr1_+_153031195 | 3.13 |
ENST00000307098.5
|
SPRR1B
|
small proline rich protein 1B |
| chr12_-_119804472 | 3.12 |
ENST00000678087.1
ENST00000677993.1 |
CIT
|
citron rho-interacting serine/threonine kinase |
| chr19_-_51034840 | 3.11 |
ENST00000529888.5
|
KLK12
|
kallikrein related peptidase 12 |
| chr1_+_153001742 | 3.10 |
ENST00000331860.7
ENST00000295367.5 ENST00000443178.1 |
SPRR3
|
small proline rich protein 3 |
| chr11_+_35186820 | 3.09 |
ENST00000531110.6
ENST00000525685.6 |
CD44
|
CD44 molecule (Indian blood group) |
| chr20_+_37383648 | 3.08 |
ENST00000373567.6
|
SRC
|
SRC proto-oncogene, non-receptor tyrosine kinase |
| chr19_-_42877988 | 3.07 |
ENST00000597058.1
|
PSG1
|
pregnancy specific beta-1-glycoprotein 1 |
| chr16_-_84504612 | 3.07 |
ENST00000562447.5
ENST00000343629.11 ENST00000565765.1 |
MEAK7
|
MTOR associated protein, eak-7 homolog |
| chr10_-_88851809 | 3.05 |
ENST00000371930.5
|
ANKRD22
|
ankyrin repeat domain 22 |
| chr1_-_204151884 | 3.03 |
ENST00000367201.7
|
ETNK2
|
ethanolamine kinase 2 |
| chrX_+_65667645 | 3.03 |
ENST00000360270.7
|
MSN
|
moesin |
| chr1_-_152414256 | 3.02 |
ENST00000271835.3
|
CRNN
|
cornulin |
| chr1_+_86547070 | 3.00 |
ENST00000370563.3
|
CLCA4
|
chloride channel accessory 4 |
| chr9_+_706841 | 2.98 |
ENST00000382293.7
|
KANK1
|
KN motif and ankyrin repeat domains 1 |
| chr3_-_149377637 | 2.97 |
ENST00000305366.8
|
TM4SF1
|
transmembrane 4 L six family member 1 |
| chr7_+_134843884 | 2.96 |
ENST00000445569.6
|
CALD1
|
caldesmon 1 |
| chr19_-_51034892 | 2.96 |
ENST00000319590.8
ENST00000250351.4 |
KLK12
|
kallikrein related peptidase 12 |
| chr15_+_67166019 | 2.96 |
ENST00000537194.6
|
SMAD3
|
SMAD family member 3 |
| chr19_-_51034993 | 2.94 |
ENST00000684732.1
|
KLK12
|
kallikrein related peptidase 12 |
| chr5_+_151212117 | 2.89 |
ENST00000523466.5
|
GM2A
|
GM2 ganglioside activator |
| chr2_+_102337148 | 2.88 |
ENST00000311734.6
ENST00000409584.5 |
IL1RL1
|
interleukin 1 receptor like 1 |
| chr19_-_11155798 | 2.87 |
ENST00000592540.5
|
SPC24
|
SPC24 component of NDC80 kinetochore complex |
| chr17_+_50634845 | 2.86 |
ENST00000427699.5
ENST00000285238.13 |
ABCC3
|
ATP binding cassette subfamily C member 3 |
| chr2_+_200585987 | 2.84 |
ENST00000374700.7
|
AOX1
|
aldehyde oxidase 1 |
| chr11_+_5596745 | 2.83 |
ENST00000445329.5
|
TRIM6
|
tripartite motif containing 6 |
| chr19_-_14778552 | 2.82 |
ENST00000315576.8
|
ADGRE2
|
adhesion G protein-coupled receptor E2 |
| chr7_+_150991005 | 2.82 |
ENST00000297494.8
|
NOS3
|
nitric oxide synthase 3 |
| chr3_-_48595267 | 2.81 |
ENST00000328333.12
ENST00000681320.1 |
COL7A1
|
collagen type VII alpha 1 chain |
| chr5_-_177496845 | 2.80 |
ENST00000506537.1
|
PDLIM7
|
PDZ and LIM domain 7 |
| chr1_-_204152010 | 2.77 |
ENST00000367202.9
|
ETNK2
|
ethanolamine kinase 2 |
| chr6_-_130956371 | 2.77 |
ENST00000639623.1
ENST00000525193.5 ENST00000527659.5 |
EPB41L2
|
erythrocyte membrane protein band 4.1 like 2 |
| chr2_+_113005454 | 2.75 |
ENST00000259211.7
|
IL36A
|
interleukin 36 alpha |
| chr14_+_94026314 | 2.74 |
ENST00000203664.10
ENST00000553723.1 |
OTUB2
|
OTU deubiquitinase, ubiquitin aldehyde binding 2 |
| chr22_+_44752552 | 2.74 |
ENST00000389774.6
ENST00000356099.11 ENST00000396119.6 ENST00000336963.8 ENST00000412433.5 |
ARHGAP8
|
Rho GTPase activating protein 8 |
| chr10_-_75109085 | 2.73 |
ENST00000607131.5
|
DUSP13
|
dual specificity phosphatase 13 |
| chr17_-_78925376 | 2.70 |
ENST00000262768.11
|
TIMP2
|
TIMP metallopeptidase inhibitor 2 |
| chr2_-_18589536 | 2.70 |
ENST00000416783.1
ENST00000359846.6 ENST00000304081.8 ENST00000532967.5 ENST00000444297.2 |
NT5C1B
NT5C1B-RDH14
|
5'-nucleotidase, cytosolic IB NT5C1B-RDH14 readthrough |
| chr15_+_67125707 | 2.68 |
ENST00000540846.6
|
SMAD3
|
SMAD family member 3 |
| chr2_-_42764116 | 2.67 |
ENST00000378661.3
|
OXER1
|
oxoeicosanoid receptor 1 |
| chr8_-_100649660 | 2.67 |
ENST00000311812.7
|
SNX31
|
sorting nexin 31 |
| chr4_+_8229170 | 2.67 |
ENST00000511002.6
|
SH3TC1
|
SH3 domain and tetratricopeptide repeats 1 |
| chr17_+_4950147 | 2.67 |
ENST00000522301.5
|
ENO3
|
enolase 3 |
| chr2_-_105396943 | 2.65 |
ENST00000409807.5
|
FHL2
|
four and a half LIM domains 2 |
| chr2_-_186849164 | 2.64 |
ENST00000295131.3
|
ZSWIM2
|
zinc finger SWIM-type containing 2 |
| chrX_+_100644183 | 2.62 |
ENST00000640889.1
ENST00000373004.5 |
SRPX2
|
sushi repeat containing protein X-linked 2 |
| chr10_+_5048748 | 2.61 |
ENST00000602997.5
ENST00000439082.7 |
AKR1C3
|
aldo-keto reductase family 1 member C3 |
| chr5_+_74685225 | 2.61 |
ENST00000261416.12
|
HEXB
|
hexosaminidase subunit beta |
| chr3_-_127736329 | 2.59 |
ENST00000398101.7
|
MGLL
|
monoglyceride lipase |
| chr4_-_155866277 | 2.58 |
ENST00000537611.3
|
ASIC5
|
acid sensing ion channel subunit family member 5 |
| chr12_-_9869345 | 2.57 |
ENST00000228438.3
|
CLEC2B
|
C-type lectin domain family 2 member B |
| chr1_+_15756659 | 2.56 |
ENST00000375771.5
|
FBLIM1
|
filamin binding LIM protein 1 |
| chr19_-_35501878 | 2.54 |
ENST00000593342.5
ENST00000601650.1 ENST00000408915.6 |
DMKN
|
dermokine |
| chr12_+_75480800 | 2.54 |
ENST00000456650.7
|
GLIPR1
|
GLI pathogenesis related 1 |
| chr17_-_78874140 | 2.54 |
ENST00000585421.5
|
TIMP2
|
TIMP metallopeptidase inhibitor 2 |
| chr1_-_110390989 | 2.53 |
ENST00000369779.9
ENST00000472422.6 |
SLC16A4
|
solute carrier family 16 member 4 |
| chr4_-_142305935 | 2.52 |
ENST00000511838.5
|
INPP4B
|
inositol polyphosphate-4-phosphatase type II B |
| chr15_-_41972504 | 2.50 |
ENST00000220325.9
|
EHD4
|
EH domain containing 4 |
| chr19_-_15934853 | 2.50 |
ENST00000620614.4
ENST00000248041.12 |
CYP4F11
|
cytochrome P450 family 4 subfamily F member 11 |
| chr5_-_16916400 | 2.49 |
ENST00000513882.5
|
MYO10
|
myosin X |
| chr10_-_128126405 | 2.49 |
ENST00000368654.8
|
MKI67
|
marker of proliferation Ki-67 |
| chr4_-_10021490 | 2.49 |
ENST00000264784.8
|
SLC2A9
|
solute carrier family 2 member 9 |
| chr2_-_219254558 | 2.48 |
ENST00000392088.6
|
TUBA4A
|
tubulin alpha 4a |
| chr9_+_128322540 | 2.48 |
ENST00000609948.1
ENST00000608951.5 |
COQ4
|
coenzyme Q4 |
| chr9_-_120877026 | 2.48 |
ENST00000436309.5
|
PHF19
|
PHD finger protein 19 |
| chr1_+_24319342 | 2.48 |
ENST00000361548.9
|
GRHL3
|
grainyhead like transcription factor 3 |
| chr6_-_39322688 | 2.47 |
ENST00000437525.3
|
KCNK16
|
potassium two pore domain channel subfamily K member 16 |
| chr3_-_48016400 | 2.46 |
ENST00000434267.5
ENST00000683076.1 ENST00000633710.1 |
MAP4
|
microtubule associated protein 4 |
| chr20_-_57711536 | 2.45 |
ENST00000265626.8
|
PMEPA1
|
prostate transmembrane protein, androgen induced 1 |
| chr1_+_163321890 | 2.45 |
ENST00000450453.6
ENST00000524800.5 ENST00000442820.5 ENST00000367900.7 |
NUF2
|
NUF2 component of NDC80 kinetochore complex |
| chr12_-_50025394 | 2.44 |
ENST00000454520.6
ENST00000546595.5 ENST00000548824.5 ENST00000549777.5 ENST00000546723.5 ENST00000427314.6 ENST00000552157.5 ENST00000552310.5 ENST00000548644.5 ENST00000546786.5 ENST00000550149.5 ENST00000546764.5 ENST00000552004.2 ENST00000548320.5 ENST00000312377.10 ENST00000547905.5 ENST00000550651.5 ENST00000551145.5 ENST00000552921.5 |
RACGAP1
|
Rac GTPase activating protein 1 |
| chr7_-_143408848 | 2.44 |
ENST00000275815.4
|
EPHA1
|
EPH receptor A1 |
| chr11_-_14891643 | 2.43 |
ENST00000532378.5
|
CYP2R1
|
cytochrome P450 family 2 subfamily R member 1 |
| chr17_-_59151794 | 2.42 |
ENST00000584089.1
|
SKA2
|
spindle and kinetochore associated complex subunit 2 |
| chr11_-_6320494 | 2.41 |
ENST00000303927.4
ENST00000530979.1 |
CAVIN3
|
caveolae associated protein 3 |
| chr12_+_75480745 | 2.40 |
ENST00000266659.8
|
GLIPR1
|
GLI pathogenesis related 1 |
| chr6_+_106086316 | 2.39 |
ENST00000369091.6
ENST00000369096.9 |
PRDM1
|
PR/SET domain 1 |
| chr4_+_83535914 | 2.34 |
ENST00000611707.4
|
GPAT3
|
glycerol-3-phosphate acyltransferase 3 |
| chr12_+_99647749 | 2.32 |
ENST00000324341.2
|
FAM71C
|
family with sequence similarity 71 member C |
| chr4_-_174522791 | 2.32 |
ENST00000541923.5
ENST00000542498.5 |
HPGD
|
15-hydroxyprostaglandin dehydrogenase |
| chr3_-_42875871 | 2.32 |
ENST00000316161.6
ENST00000437102.1 |
CYP8B1
|
cytochrome P450 family 8 subfamily B member 1 |
| chr2_-_88992903 | 2.32 |
ENST00000495489.1
|
IGKV1-8
|
immunoglobulin kappa variable 1-8 |
| chr20_-_1325707 | 2.31 |
ENST00000381812.5
|
SDCBP2
|
syndecan binding protein 2 |
| chr19_+_38789198 | 2.31 |
ENST00000314980.5
|
LGALS7B
|
galectin 7B |
| chr4_+_83536097 | 2.29 |
ENST00000395226.6
ENST00000264409.5 |
GPAT3
|
glycerol-3-phosphate acyltransferase 3 |
| chr17_-_61863327 | 2.29 |
ENST00000584322.2
ENST00000682369.1 ENST00000683039.1 ENST00000683381.1 |
BRIP1
|
BRCA1 interacting protein C-terminal helicase 1 |
| chr22_-_37188233 | 2.28 |
ENST00000434784.1
ENST00000337843.7 |
C1QTNF6
|
C1q and TNF related 6 |
| chr3_-_98522514 | 2.27 |
ENST00000503004.5
ENST00000506575.1 ENST00000513452.5 ENST00000515620.5 |
CLDND1
|
claudin domain containing 1 |
| chr1_-_110391041 | 2.27 |
ENST00000369781.8
ENST00000437429.6 ENST00000541986.5 |
SLC16A4
|
solute carrier family 16 member 4 |
| chr17_-_41397600 | 2.26 |
ENST00000251645.3
|
KRT31
|
keratin 31 |
| chr18_+_58671517 | 2.26 |
ENST00000345724.7
|
MALT1
|
MALT1 paracaspase |
| chr12_-_53200443 | 2.24 |
ENST00000550743.6
|
ITGB7
|
integrin subunit beta 7 |
| chr19_-_38773432 | 2.23 |
ENST00000599035.1
ENST00000378626.5 |
LGALS7
|
galectin 7 |
| chr19_-_43781249 | 2.23 |
ENST00000615047.4
|
KCNN4
|
potassium calcium-activated channel subfamily N member 4 |
Gene Ontology Analysis
Gene overrepresentation in biological process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 4.2 | 12.7 | GO:0046108 | uridine metabolic process(GO:0046108) |
| 3.6 | 21.8 | GO:0061143 | alveolar primary septum development(GO:0061143) |
| 2.9 | 8.6 | GO:0060559 | positive regulation of vitamin metabolic process(GO:0046136) positive regulation of vitamin D biosynthetic process(GO:0060557) positive regulation of calcidiol 1-monooxygenase activity(GO:0060559) |
| 2.8 | 14.1 | GO:0090362 | positive regulation of platelet-derived growth factor production(GO:0090362) |
| 2.5 | 10.1 | GO:0044837 | assembly of actomyosin apparatus involved in cytokinesis(GO:0000912) actomyosin contractile ring assembly(GO:0000915) actomyosin contractile ring organization(GO:0044837) |
| 2.4 | 7.2 | GO:0014740 | negative regulation of muscle hyperplasia(GO:0014740) |
| 2.3 | 14.1 | GO:0002225 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antibacterial peptide production(GO:0002803) |
| 1.5 | 4.5 | GO:0046521 | sphingoid catabolic process(GO:0046521) |
| 1.4 | 4.2 | GO:0038158 | granulocyte colony-stimulating factor signaling pathway(GO:0038158) |
| 1.4 | 8.4 | GO:0032487 | regulation of Rap protein signal transduction(GO:0032487) |
| 1.3 | 15.7 | GO:0010820 | positive regulation of T cell chemotaxis(GO:0010820) |
| 1.3 | 3.8 | GO:0033082 | regulation of extrathymic T cell differentiation(GO:0033082) sebum secreting cell proliferation(GO:1990654) |
| 1.3 | 3.8 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
| 1.3 | 6.3 | GO:0072675 | multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
| 1.2 | 7.2 | GO:0007296 | vitellogenesis(GO:0007296) |
| 1.2 | 3.5 | GO:0051821 | negative regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage(GO:0010768) transmission of virus(GO:0019089) dissemination or transmission of symbiont from host(GO:0044007) dissemination or transmission of organism from other organism involved in symbiotic interaction(GO:0051821) |
| 1.1 | 3.4 | GO:2000224 | sesquiterpenoid metabolic process(GO:0006714) sesquiterpenoid catabolic process(GO:0016107) farnesol metabolic process(GO:0016487) farnesol catabolic process(GO:0016488) regulation of testosterone biosynthetic process(GO:2000224) |
| 1.1 | 3.2 | GO:0033242 | regulation of cellular amine catabolic process(GO:0033241) negative regulation of cellular amine catabolic process(GO:0033242) negative regulation of the force of heart contraction(GO:0098736) regulation of arginine catabolic process(GO:1900081) negative regulation of arginine catabolic process(GO:1900082) regulation of citrulline biosynthetic process(GO:1903248) negative regulation of citrulline biosynthetic process(GO:1903249) negative regulation of cellular amino acid biosynthetic process(GO:2000283) |
| 1.1 | 6.5 | GO:0061767 | negative regulation of lung blood pressure(GO:0061767) |
| 1.0 | 7.1 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
| 1.0 | 4.1 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
| 0.9 | 2.8 | GO:0046110 | xanthine metabolic process(GO:0046110) |
| 0.9 | 10.1 | GO:1903944 | regulation of hepatocyte apoptotic process(GO:1903943) negative regulation of hepatocyte apoptotic process(GO:1903944) |
| 0.9 | 1.8 | GO:0002581 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) |
| 0.8 | 22.8 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
| 0.8 | 3.2 | GO:2000393 | negative regulation of lamellipodium morphogenesis(GO:2000393) |
| 0.8 | 2.4 | GO:0043465 | fermentation(GO:0006113) regulation of fermentation(GO:0043465) |
| 0.8 | 0.8 | GO:1901740 | negative regulation of myoblast fusion(GO:1901740) |
| 0.8 | 11.0 | GO:0031642 | negative regulation of myelination(GO:0031642) |
| 0.7 | 2.2 | GO:0003366 | cell-matrix adhesion involved in ameboidal cell migration(GO:0003366) |
| 0.7 | 7.3 | GO:0060005 | vestibular reflex(GO:0060005) |
| 0.7 | 2.9 | GO:0002159 | desmosome assembly(GO:0002159) |
| 0.7 | 2.9 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
| 0.7 | 2.8 | GO:0042377 | menaquinone catabolic process(GO:0042361) vitamin K catabolic process(GO:0042377) |
| 0.7 | 2.1 | GO:0018874 | benzoate metabolic process(GO:0018874) |
| 0.7 | 6.3 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
| 0.7 | 6.9 | GO:1902714 | negative regulation of interferon-gamma secretion(GO:1902714) |
| 0.7 | 5.4 | GO:0035879 | plasma membrane lactate transport(GO:0035879) |
| 0.7 | 2.7 | GO:0055011 | atrial cardiac muscle cell differentiation(GO:0055011) atrial cardiac muscle cell development(GO:0055014) |
| 0.7 | 6.5 | GO:0002741 | positive regulation of cytokine secretion involved in immune response(GO:0002741) |
| 0.6 | 2.6 | GO:0007206 | phospholipase C-activating G-protein coupled glutamate receptor signaling pathway(GO:0007206) |
| 0.6 | 2.5 | GO:1903575 | cornified envelope assembly(GO:1903575) |
| 0.6 | 1.9 | GO:0038195 | urokinase plasminogen activator signaling pathway(GO:0038195) |
| 0.6 | 1.2 | GO:0010751 | negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
| 0.6 | 4.3 | GO:2000660 | negative regulation of interleukin-1-mediated signaling pathway(GO:2000660) |
| 0.6 | 38.5 | GO:0018149 | peptide cross-linking(GO:0018149) |
| 0.6 | 16.2 | GO:2000404 | regulation of T cell migration(GO:2000404) |
| 0.6 | 1.8 | GO:0014810 | positive regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion(GO:0014810) |
| 0.6 | 3.5 | GO:0001923 | B-1 B cell differentiation(GO:0001923) |
| 0.6 | 2.3 | GO:0000706 | meiotic DNA double-strand break processing(GO:0000706) double-strand break repair involved in meiotic recombination(GO:1990918) |
| 0.6 | 10.3 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
| 0.6 | 2.2 | GO:0009753 | response to jasmonic acid(GO:0009753) cellular response to jasmonic acid stimulus(GO:0071395) |
| 0.5 | 1.1 | GO:0034242 | negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) |
| 0.5 | 2.1 | GO:0002384 | hepatic immune response(GO:0002384) |
| 0.5 | 3.7 | GO:0060467 | negative regulation of fertilization(GO:0060467) |
| 0.5 | 2.1 | GO:0018101 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
| 0.5 | 2.1 | GO:0046946 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
| 0.5 | 3.0 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) |
| 0.5 | 1.5 | GO:0086092 | regulation of the force of heart contraction by cardiac conduction(GO:0086092) positive regulation of calcium:sodium antiporter activity(GO:1903281) |
| 0.5 | 2.0 | GO:0006175 | adenosine salvage(GO:0006169) dATP biosynthetic process(GO:0006175) |
| 0.5 | 2.4 | GO:0036378 | calcitriol biosynthetic process from calciol(GO:0036378) |
| 0.5 | 1.4 | GO:0018963 | phthalate metabolic process(GO:0018963) epinephrine biosynthetic process(GO:0042418) |
| 0.5 | 2.9 | GO:0033274 | response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
| 0.5 | 9.5 | GO:1904778 | regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
| 0.5 | 0.9 | GO:0097325 | melanocyte proliferation(GO:0097325) |
| 0.5 | 2.4 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
| 0.5 | 1.4 | GO:0006045 | N-acetylglucosamine biosynthetic process(GO:0006045) glucosamine-containing compound biosynthetic process(GO:1901073) |
| 0.5 | 2.4 | GO:0001306 | age-dependent response to oxidative stress(GO:0001306) age-dependent response to reactive oxygen species(GO:0001315) regulation of systemic arterial blood pressure by acetylcholine(GO:0003068) vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure(GO:0003069) regulation of systemic arterial blood pressure by neurotransmitter(GO:0003070) age-dependent general metabolic decline(GO:0007571) |
| 0.5 | 2.3 | GO:0033384 | geranyl diphosphate metabolic process(GO:0033383) geranyl diphosphate biosynthetic process(GO:0033384) farnesyl diphosphate biosynthetic process(GO:0045337) |
| 0.5 | 10.5 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
| 0.5 | 1.8 | GO:0046900 | tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
| 0.5 | 5.4 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
| 0.4 | 3.6 | GO:2000467 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) positive regulation of glycogen (starch) synthase activity(GO:2000467) |
| 0.4 | 1.8 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
| 0.4 | 1.8 | GO:0035803 | egg coat formation(GO:0035803) |
| 0.4 | 1.3 | GO:0034635 | glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
| 0.4 | 7.0 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
| 0.4 | 1.7 | GO:1903438 | regulation of cytokinetic process(GO:0032954) regulation of mitotic cytokinetic process(GO:1903436) positive regulation of mitotic cytokinetic process(GO:1903438) positive regulation of mitotic cytokinesis(GO:1903490) |
| 0.4 | 1.3 | GO:1903033 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) |
| 0.4 | 3.3 | GO:0032962 | positive regulation of inositol trisphosphate biosynthetic process(GO:0032962) |
| 0.4 | 7.5 | GO:0051546 | keratinocyte migration(GO:0051546) |
| 0.4 | 3.3 | GO:0072526 | pyridine-containing compound catabolic process(GO:0072526) |
| 0.4 | 7.8 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
| 0.4 | 1.6 | GO:0086097 | phospholipase C-activating angiotensin-activated signaling pathway(GO:0086097) |
| 0.4 | 2.9 | GO:0038172 | interleukin-33-mediated signaling pathway(GO:0038172) |
| 0.4 | 3.3 | GO:0070543 | response to linoleic acid(GO:0070543) blood microparticle formation(GO:0072564) regulation of blood microparticle formation(GO:2000332) positive regulation of blood microparticle formation(GO:2000334) |
| 0.4 | 2.5 | GO:0051012 | microtubule sliding(GO:0051012) |
| 0.4 | 11.8 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
| 0.4 | 1.2 | GO:0061300 | cerebellum vasculature development(GO:0061300) |
| 0.4 | 2.4 | GO:0019060 | intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
| 0.4 | 2.4 | GO:0036015 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
| 0.4 | 1.9 | GO:0003350 | pulmonary myocardium development(GO:0003350) |
| 0.4 | 4.9 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
| 0.4 | 1.8 | GO:0061370 | testosterone biosynthetic process(GO:0061370) |
| 0.4 | 1.1 | GO:0045553 | TRAIL biosynthetic process(GO:0045553) regulation of TRAIL biosynthetic process(GO:0045554) positive regulation of TRAIL biosynthetic process(GO:0045556) |
| 0.4 | 4.8 | GO:0015803 | branched-chain amino acid transport(GO:0015803) |
| 0.4 | 1.1 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
| 0.4 | 0.7 | GO:0051586 | positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
| 0.4 | 4.6 | GO:0036155 | acylglycerol acyl-chain remodeling(GO:0036155) |
| 0.4 | 1.8 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
| 0.4 | 1.4 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
| 0.3 | 3.5 | GO:0051013 | microtubule severing(GO:0051013) |
| 0.3 | 2.1 | GO:1903566 | positive regulation of protein localization to cilium(GO:1903566) |
| 0.3 | 1.4 | GO:2001202 | gamma-delta T cell activation involved in immune response(GO:0002290) negative regulation of interferon-beta secretion(GO:0035548) regulation of gamma-delta T cell activation involved in immune response(GO:2001191) positive regulation of gamma-delta T cell activation involved in immune response(GO:2001193) regulation of transforming growth factor-beta secretion(GO:2001201) negative regulation of transforming growth factor-beta secretion(GO:2001202) |
| 0.3 | 2.4 | GO:2000230 | negative regulation of pancreatic stellate cell proliferation(GO:2000230) |
| 0.3 | 2.4 | GO:1905123 | regulation of glucosylceramidase activity(GO:1905123) |
| 0.3 | 3.3 | GO:0008063 | Toll signaling pathway(GO:0008063) |
| 0.3 | 2.0 | GO:0007079 | mitotic chromosome movement towards spindle pole(GO:0007079) |
| 0.3 | 3.0 | GO:0070649 | formin-nucleated actin cable assembly(GO:0070649) |
| 0.3 | 2.3 | GO:0097070 | ductus arteriosus closure(GO:0097070) |
| 0.3 | 1.0 | GO:0035425 | autocrine signaling(GO:0035425) |
| 0.3 | 1.3 | GO:1904744 | positive regulation of telomeric DNA binding(GO:1904744) |
| 0.3 | 8.8 | GO:0032060 | bleb assembly(GO:0032060) |
| 0.3 | 1.9 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
| 0.3 | 3.1 | GO:1900623 | regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
| 0.3 | 1.5 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
| 0.3 | 0.9 | GO:0046603 | negative regulation of mitotic centrosome separation(GO:0046603) |
| 0.3 | 1.2 | GO:2000687 | negative regulation of rubidium ion transport(GO:2000681) negative regulation of rubidium ion transmembrane transporter activity(GO:2000687) |
| 0.3 | 3.8 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
| 0.3 | 4.1 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
| 0.3 | 0.3 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
| 0.3 | 1.4 | GO:0071163 | DNA replication preinitiation complex assembly(GO:0071163) |
| 0.3 | 1.7 | GO:0006041 | glucosamine metabolic process(GO:0006041) |
| 0.3 | 6.0 | GO:0070208 | protein heterotrimerization(GO:0070208) |
| 0.3 | 0.6 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
| 0.3 | 2.5 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
| 0.3 | 1.7 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
| 0.3 | 0.8 | GO:1903028 | positive regulation of opsonization(GO:1903028) |
| 0.3 | 0.8 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
| 0.3 | 1.1 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
| 0.3 | 0.3 | GO:0052047 | interaction with other organism via secreted substance involved in symbiotic interaction(GO:0052047) |
| 0.3 | 0.8 | GO:1903717 | carbamoyl phosphate metabolic process(GO:0070408) carbamoyl phosphate biosynthetic process(GO:0070409) cellular response to oleic acid(GO:0071400) response to ammonia(GO:1903717) cellular response to ammonia(GO:1903718) |
| 0.3 | 0.8 | GO:0009258 | 10-formyltetrahydrofolate catabolic process(GO:0009258) |
| 0.3 | 2.4 | GO:0042904 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
| 0.3 | 0.8 | GO:1902869 | commitment of multipotent stem cells to neuronal lineage in forebrain(GO:0021898) regulation of amacrine cell differentiation(GO:1902869) |
| 0.3 | 0.8 | GO:1905237 | response to cyclosporin A(GO:1905237) positive regulation of response to drug(GO:2001025) |
| 0.3 | 0.8 | GO:0003383 | apical constriction(GO:0003383) |
| 0.3 | 2.1 | GO:2001023 | cellular response to cisplatin(GO:0072719) regulation of response to drug(GO:2001023) |
| 0.3 | 1.8 | GO:2000969 | positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
| 0.3 | 0.8 | GO:0060723 | spongiotrophoblast cell proliferation(GO:0060720) regulation of spongiotrophoblast cell proliferation(GO:0060721) cell proliferation involved in embryonic placenta development(GO:0060722) regulation of cell proliferation involved in embryonic placenta development(GO:0060723) |
| 0.3 | 0.5 | GO:0016999 | antibiotic metabolic process(GO:0016999) |
| 0.3 | 0.3 | GO:2000359 | regulation of binding of sperm to zona pellucida(GO:2000359) |
| 0.2 | 1.5 | GO:0010897 | negative regulation of triglyceride catabolic process(GO:0010897) secretory granule localization(GO:0032252) |
| 0.2 | 2.5 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
| 0.2 | 0.7 | GO:1903644 | regulation of chaperone-mediated protein folding(GO:1903644) |
| 0.2 | 1.7 | GO:0097338 | response to clozapine(GO:0097338) |
| 0.2 | 1.0 | GO:0050960 | detection of temperature stimulus involved in thermoception(GO:0050960) response to capsazepine(GO:1901594) |
| 0.2 | 1.9 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
| 0.2 | 1.9 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
| 0.2 | 1.9 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
| 0.2 | 0.7 | GO:0009085 | lysine biosynthetic process(GO:0009085) lysine biosynthetic process via aminoadipic acid(GO:0019878) |
| 0.2 | 23.8 | GO:0070268 | cornification(GO:0070268) |
| 0.2 | 4.0 | GO:0046415 | urate metabolic process(GO:0046415) |
| 0.2 | 0.7 | GO:0002752 | cell surface pattern recognition receptor signaling pathway(GO:0002752) |
| 0.2 | 1.4 | GO:0045338 | ergosterol biosynthetic process(GO:0006696) ergosterol metabolic process(GO:0008204) cellular alcohol metabolic process(GO:0044107) cellular alcohol biosynthetic process(GO:0044108) farnesyl diphosphate metabolic process(GO:0045338) |
| 0.2 | 0.7 | GO:0042322 | negative regulation of circadian sleep/wake cycle, REM sleep(GO:0042322) positive regulation of eating behavior(GO:1904000) regulation of small intestine smooth muscle contraction(GO:1904347) positive regulation of small intestine smooth muscle contraction(GO:1904349) small intestine smooth muscle contraction(GO:1990770) negative regulation of energy homeostasis(GO:2000506) |
| 0.2 | 20.7 | GO:0030574 | collagen catabolic process(GO:0030574) |
| 0.2 | 1.1 | GO:0035873 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) |
| 0.2 | 0.9 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
| 0.2 | 0.9 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
| 0.2 | 5.8 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
| 0.2 | 1.3 | GO:0031627 | telomeric loop formation(GO:0031627) |
| 0.2 | 1.1 | GO:0071802 | negative regulation of podosome assembly(GO:0071802) |
| 0.2 | 0.6 | GO:0006642 | triglyceride mobilization(GO:0006642) |
| 0.2 | 0.6 | GO:0071484 | cellular response to light intensity(GO:0071484) cellular response to high light intensity(GO:0071486) retinal rod cell apoptotic process(GO:0097473) retinal cell apoptotic process(GO:1990009) |
| 0.2 | 1.0 | GO:1902713 | regulation of interferon-gamma secretion(GO:1902713) |
| 0.2 | 1.9 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
| 0.2 | 0.2 | GO:0046666 | retinal cell programmed cell death(GO:0046666) |
| 0.2 | 0.8 | GO:1904304 | regulation of gastro-intestinal system smooth muscle contraction(GO:1904304) positive regulation of gastro-intestinal system smooth muscle contraction(GO:1904306) |
| 0.2 | 1.4 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
| 0.2 | 2.6 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
| 0.2 | 1.6 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
| 0.2 | 1.0 | GO:0035992 | tendon development(GO:0035989) tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
| 0.2 | 0.2 | GO:0045799 | positive regulation of chromatin assembly or disassembly(GO:0045799) |
| 0.2 | 0.6 | GO:0032416 | negative regulation of sodium:proton antiporter activity(GO:0032416) |
| 0.2 | 9.2 | GO:0050832 | defense response to fungus(GO:0050832) |
| 0.2 | 2.9 | GO:0019388 | galactose catabolic process(GO:0019388) |
| 0.2 | 1.3 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
| 0.2 | 0.2 | GO:0051343 | positive regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051343) |
| 0.2 | 3.6 | GO:0060973 | cell migration involved in heart development(GO:0060973) |
| 0.2 | 0.6 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
| 0.2 | 0.6 | GO:0007518 | myoblast fate determination(GO:0007518) |
| 0.2 | 1.1 | GO:0034196 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
| 0.2 | 0.6 | GO:0042938 | dipeptide transport(GO:0042938) |
| 0.2 | 1.5 | GO:0016114 | terpenoid biosynthetic process(GO:0016114) |
| 0.2 | 1.9 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
| 0.2 | 1.1 | GO:0033490 | cholesterol biosynthetic process via desmosterol(GO:0033489) cholesterol biosynthetic process via lathosterol(GO:0033490) |
| 0.2 | 3.1 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
| 0.2 | 7.3 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
| 0.2 | 5.1 | GO:0051290 | protein heterotetramerization(GO:0051290) |
| 0.2 | 1.3 | GO:2000320 | negative regulation of T-helper 17 type immune response(GO:2000317) negative regulation of T-helper 17 cell differentiation(GO:2000320) |
| 0.2 | 2.2 | GO:0097283 | keratinocyte apoptotic process(GO:0097283) regulation of keratinocyte apoptotic process(GO:1902172) |
| 0.2 | 1.1 | GO:0010025 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
| 0.2 | 0.9 | GO:0072092 | ureteric bud invasion(GO:0072092) |
| 0.2 | 0.4 | GO:1902938 | regulation of intracellular calcium activated chloride channel activity(GO:1902938) |
| 0.2 | 0.5 | GO:0060672 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
| 0.2 | 0.5 | GO:0018013 | N-terminal protein amino acid methylation(GO:0006480) N-terminal peptidyl-alanine methylation(GO:0018011) N-terminal peptidyl-alanine trimethylation(GO:0018012) N-terminal peptidyl-glycine methylation(GO:0018013) N-terminal peptidyl-proline dimethylation(GO:0018016) peptidyl-alanine modification(GO:0018194) N-terminal peptidyl-proline methylation(GO:0035568) N-terminal peptidyl-serine methylation(GO:0035570) N-terminal peptidyl-serine dimethylation(GO:0035572) N-terminal peptidyl-serine trimethylation(GO:0035573) |
| 0.2 | 1.0 | GO:0030311 | poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
| 0.2 | 0.9 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
| 0.2 | 1.0 | GO:0006657 | CDP-choline pathway(GO:0006657) |
| 0.2 | 2.1 | GO:0019532 | oxalate transport(GO:0019532) |
| 0.2 | 0.7 | GO:0010593 | negative regulation of lamellipodium assembly(GO:0010593) |
| 0.2 | 0.3 | GO:0019285 | glycine betaine biosynthetic process from choline(GO:0019285) glycine betaine metabolic process(GO:0031455) glycine betaine biosynthetic process(GO:0031456) |
| 0.2 | 3.8 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
| 0.2 | 2.1 | GO:1990000 | amyloid fibril formation(GO:1990000) |
| 0.2 | 0.8 | GO:1901569 | leukotriene catabolic process(GO:0036100) leukotriene B4 catabolic process(GO:0036101) leukotriene B4 metabolic process(GO:0036102) icosanoid catabolic process(GO:1901523) fatty acid derivative catabolic process(GO:1901569) |
| 0.2 | 1.0 | GO:0019918 | peptidyl-arginine methylation, to symmetrical-dimethyl arginine(GO:0019918) |
| 0.2 | 1.1 | GO:0035655 | interleukin-18-mediated signaling pathway(GO:0035655) cellular response to interleukin-18(GO:0071351) |
| 0.2 | 2.3 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
| 0.2 | 0.6 | GO:2000612 | thyroid-stimulating hormone secretion(GO:0070460) metanephric comma-shaped body morphogenesis(GO:0072278) regulation of thyroid-stimulating hormone secretion(GO:2000612) |
| 0.2 | 0.6 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
| 0.2 | 1.6 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
| 0.2 | 1.4 | GO:0060017 | parathyroid gland development(GO:0060017) |
| 0.2 | 0.3 | GO:0045082 | positive regulation of interleukin-10 biosynthetic process(GO:0045082) |
| 0.2 | 1.4 | GO:0051852 | disruption by host of symbiont cells(GO:0051852) killing by host of symbiont cells(GO:0051873) |
| 0.2 | 2.5 | GO:0090179 | planar cell polarity pathway involved in neural tube closure(GO:0090179) |
| 0.2 | 1.4 | GO:0021999 | neural plate anterior/posterior regionalization(GO:0021999) |
| 0.2 | 0.9 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
| 0.2 | 0.6 | GO:1905229 | cellular response to glycoprotein(GO:1904588) cellular response to thyrotropin-releasing hormone(GO:1905229) |
| 0.1 | 1.0 | GO:2000490 | negative regulation of hepatic stellate cell activation(GO:2000490) |
| 0.1 | 0.4 | GO:0001189 | RNA polymerase I transcriptional preinitiation complex assembly(GO:0001188) RNA polymerase I transcriptional preinitiation complex assembly at the promoter for the nuclear large rRNA transcript(GO:0001189) |
| 0.1 | 3.0 | GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
| 0.1 | 3.6 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
| 0.1 | 0.7 | GO:0032264 | IMP salvage(GO:0032264) |
| 0.1 | 1.8 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
| 0.1 | 0.9 | GO:0032445 | fructose transport(GO:0015755) fructose import(GO:0032445) carbohydrate import into cell(GO:0097319) carbohydrate import across plasma membrane(GO:0098704) fructose import across plasma membrane(GO:1990539) |
| 0.1 | 1.6 | GO:0060613 | fat pad development(GO:0060613) |
| 0.1 | 0.9 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
| 0.1 | 1.1 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
| 0.1 | 1.7 | GO:0007021 | tubulin complex assembly(GO:0007021) |
| 0.1 | 1.0 | GO:0036462 | TRAIL-activated apoptotic signaling pathway(GO:0036462) |
| 0.1 | 5.8 | GO:0008053 | mitochondrial fusion(GO:0008053) |
| 0.1 | 5.4 | GO:0039694 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
| 0.1 | 4.2 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
| 0.1 | 0.8 | GO:2000158 | positive regulation of ubiquitin-specific protease activity(GO:2000158) |
| 0.1 | 0.6 | GO:0072603 | interleukin-5 secretion(GO:0072603) regulation of interleukin-5 secretion(GO:2000662) positive regulation of interleukin-5 secretion(GO:2000664) |
| 0.1 | 0.8 | GO:0051621 | negative regulation of dopamine uptake involved in synaptic transmission(GO:0051585) norepinephrine uptake(GO:0051620) regulation of norepinephrine uptake(GO:0051621) negative regulation of norepinephrine uptake(GO:0051622) negative regulation of catecholamine uptake involved in synaptic transmission(GO:0051945) regulation of glutathione peroxidase activity(GO:1903282) positive regulation of glutathione peroxidase activity(GO:1903284) positive regulation of hydrogen peroxide catabolic process(GO:1903285) regulation of peroxidase activity(GO:2000468) positive regulation of peroxidase activity(GO:2000470) |
| 0.1 | 1.8 | GO:0015693 | magnesium ion transport(GO:0015693) |
| 0.1 | 6.3 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
| 0.1 | 0.4 | GO:0009436 | glyoxylate catabolic process(GO:0009436) |
| 0.1 | 0.9 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
| 0.1 | 0.4 | GO:0002572 | pro-T cell differentiation(GO:0002572) regulation of pro-T cell differentiation(GO:2000174) positive regulation of pro-T cell differentiation(GO:2000176) |
| 0.1 | 0.4 | GO:0046338 | phosphatidylethanolamine catabolic process(GO:0046338) |
| 0.1 | 0.7 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
| 0.1 | 0.1 | GO:0060623 | regulation of chromosome condensation(GO:0060623) |
| 0.1 | 0.5 | GO:2000553 | regulation of T-helper 2 cell cytokine production(GO:2000551) positive regulation of T-helper 2 cell cytokine production(GO:2000553) |
| 0.1 | 2.6 | GO:1902043 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
| 0.1 | 0.3 | GO:0001180 | transcription initiation from RNA polymerase I promoter for nuclear large rRNA transcript(GO:0001180) |
| 0.1 | 0.4 | GO:0042776 | mitochondrial ATP synthesis coupled proton transport(GO:0042776) |
| 0.1 | 0.6 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
| 0.1 | 1.4 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
| 0.1 | 0.9 | GO:0048845 | venous blood vessel morphogenesis(GO:0048845) |
| 0.1 | 0.5 | GO:0038098 | sequestering of BMP from receptor via BMP binding(GO:0038098) |
| 0.1 | 4.5 | GO:0032435 | negative regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032435) |
| 0.1 | 0.5 | GO:0021634 | optic nerve formation(GO:0021634) ureter maturation(GO:0035799) pronephric field specification(GO:0039003) pattern specification involved in pronephros development(GO:0039017) optic chiasma development(GO:0061360) kidney field specification(GO:0072004) regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis(GO:0072304) negative regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis(GO:0072305) mesenchymal stem cell maintenance involved in metanephric nephron morphogenesis(GO:0072309) apoptotic process involved in metanephric collecting duct development(GO:1900204) apoptotic process involved in metanephric nephron tubule development(GO:1900205) regulation of apoptotic process involved in metanephric collecting duct development(GO:1900214) negative regulation of apoptotic process involved in metanephric collecting duct development(GO:1900215) regulation of apoptotic process involved in metanephric nephron tubule development(GO:1900217) negative regulation of apoptotic process involved in metanephric nephron tubule development(GO:1900218) mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis(GO:1901147) regulation of metanephric DCT cell differentiation(GO:2000592) positive regulation of metanephric DCT cell differentiation(GO:2000594) regulation of optic nerve formation(GO:2000595) positive regulation of optic nerve formation(GO:2000597) |
| 0.1 | 1.5 | GO:0070315 | G1 to G0 transition involved in cell differentiation(GO:0070315) |
| 0.1 | 1.0 | GO:0060677 | ureteric bud elongation(GO:0060677) branch elongation involved in ureteric bud branching(GO:0060681) |
| 0.1 | 4.3 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
| 0.1 | 0.6 | GO:0015862 | uridine transport(GO:0015862) |
| 0.1 | 1.8 | GO:0060707 | trophoblast giant cell differentiation(GO:0060707) |
| 0.1 | 0.4 | GO:1990523 | bone regeneration(GO:1990523) |
| 0.1 | 0.5 | GO:0070309 | lens fiber cell morphogenesis(GO:0070309) |
| 0.1 | 0.4 | GO:0006500 | N-terminal protein palmitoylation(GO:0006500) |
| 0.1 | 0.4 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
| 0.1 | 0.4 | GO:1903862 | positive regulation of oxidative phosphorylation(GO:1903862) |
| 0.1 | 0.5 | GO:0046878 | positive regulation of saliva secretion(GO:0046878) |
| 0.1 | 0.3 | GO:0098507 | polynucleotide 5' dephosphorylation(GO:0098507) |
| 0.1 | 1.1 | GO:0071492 | cellular response to UV-A(GO:0071492) |
| 0.1 | 0.5 | GO:0021684 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
| 0.1 | 1.2 | GO:0090344 | negative regulation of cell aging(GO:0090344) |
| 0.1 | 0.5 | GO:0061763 | multivesicular body-lysosome fusion(GO:0061763) |
| 0.1 | 5.5 | GO:2000816 | negative regulation of mitotic sister chromatid separation(GO:2000816) |
| 0.1 | 0.3 | GO:0000117 | regulation of transcription involved in G2/M transition of mitotic cell cycle(GO:0000117) |
| 0.1 | 1.3 | GO:0038065 | collagen-activated signaling pathway(GO:0038065) |
| 0.1 | 0.7 | GO:0016078 | tRNA catabolic process(GO:0016078) |
| 0.1 | 0.3 | GO:1902283 | negative regulation of primary amine oxidase activity(GO:1902283) |
| 0.1 | 0.8 | GO:0006012 | galactose metabolic process(GO:0006012) |
| 0.1 | 0.8 | GO:0006001 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) |
| 0.1 | 0.3 | GO:0061739 | protein lipidation involved in autophagosome assembly(GO:0061739) |
| 0.1 | 1.0 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
| 0.1 | 0.2 | GO:0002268 | follicular dendritic cell differentiation(GO:0002268) |
| 0.1 | 0.3 | GO:0051142 | regulation of NK T cell proliferation(GO:0051140) positive regulation of NK T cell proliferation(GO:0051142) |
| 0.1 | 0.7 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
| 0.1 | 0.8 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
| 0.1 | 2.2 | GO:0007567 | parturition(GO:0007567) |
| 0.1 | 0.6 | GO:0051552 | flavone metabolic process(GO:0051552) |
| 0.1 | 0.4 | GO:0036229 | glutamine secretion(GO:0010585) L-glutamine import(GO:0036229) L-glutamine import into cell(GO:1903803) |
| 0.1 | 1.4 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
| 0.1 | 1.2 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
| 0.1 | 0.5 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
| 0.1 | 0.9 | GO:0035878 | nail development(GO:0035878) |
| 0.1 | 0.4 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
| 0.1 | 0.3 | GO:0046725 | negative regulation by virus of viral protein levels in host cell(GO:0046725) negative regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072308) |
| 0.1 | 0.7 | GO:0007598 | blood coagulation, extrinsic pathway(GO:0007598) |
| 0.1 | 0.9 | GO:0033623 | regulation of integrin activation(GO:0033623) |
| 0.1 | 0.6 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
| 0.1 | 0.6 | GO:0090237 | regulation of arachidonic acid secretion(GO:0090237) positive regulation of arachidonic acid secretion(GO:0090238) |
| 0.1 | 0.4 | GO:0034334 | adherens junction maintenance(GO:0034334) |
| 0.1 | 1.2 | GO:0043249 | erythrocyte maturation(GO:0043249) |
| 0.1 | 0.5 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
| 0.1 | 0.2 | GO:0031247 | actin rod assembly(GO:0031247) |
| 0.1 | 5.2 | GO:1901998 | toxin transport(GO:1901998) |
| 0.1 | 0.7 | GO:0070314 | G1 to G0 transition(GO:0070314) |
| 0.1 | 0.3 | GO:0099545 | trans-synaptic signaling by trans-synaptic complex(GO:0099545) trans-synaptic signaling by trans-synaptic complex, modulating synaptic transmission(GO:0099557) |
| 0.1 | 2.6 | GO:0043403 | skeletal muscle tissue regeneration(GO:0043403) |
| 0.1 | 1.2 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
| 0.1 | 1.5 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
| 0.1 | 2.8 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
| 0.1 | 0.2 | GO:0001545 | primary ovarian follicle growth(GO:0001545) |
| 0.1 | 4.5 | GO:0045669 | positive regulation of osteoblast differentiation(GO:0045669) |
| 0.1 | 1.5 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
| 0.1 | 2.1 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
| 0.1 | 0.2 | GO:0032571 | response to vitamin K(GO:0032571) |
| 0.1 | 0.6 | GO:0071105 | response to interleukin-11(GO:0071105) |
| 0.1 | 2.3 | GO:1901663 | ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
| 0.1 | 7.6 | GO:0003254 | regulation of membrane depolarization(GO:0003254) |
| 0.1 | 4.1 | GO:0006308 | DNA catabolic process(GO:0006308) |
| 0.1 | 1.0 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
| 0.1 | 2.0 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
| 0.1 | 1.3 | GO:0003334 | keratinocyte development(GO:0003334) |
| 0.1 | 2.9 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
| 0.1 | 0.8 | GO:0007068 | negative regulation of transcription during mitosis(GO:0007068) negative regulation of transcription from RNA polymerase II promoter during mitosis(GO:0007070) |
| 0.1 | 0.9 | GO:0072540 | T-helper 17 cell lineage commitment(GO:0072540) |
| 0.1 | 0.8 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) |
| 0.1 | 0.3 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) positive regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061419) |
| 0.1 | 2.6 | GO:0006509 | membrane protein ectodomain proteolysis(GO:0006509) |
| 0.1 | 14.9 | GO:0002377 | immunoglobulin production(GO:0002377) |
| 0.1 | 0.5 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
| 0.1 | 0.7 | GO:1901727 | positive regulation of histone deacetylase activity(GO:1901727) |
| 0.1 | 1.0 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
| 0.1 | 2.1 | GO:0006465 | signal peptide processing(GO:0006465) |
| 0.1 | 6.0 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
| 0.1 | 0.3 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
| 0.1 | 1.4 | GO:0006553 | lysine metabolic process(GO:0006553) lysine catabolic process(GO:0006554) |
| 0.1 | 0.3 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
| 0.1 | 0.3 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
| 0.1 | 1.4 | GO:2000828 | parathyroid hormone secretion(GO:0035898) post-embryonic body morphogenesis(GO:0040032) regulation of parathyroid hormone secretion(GO:2000828) |
| 0.1 | 1.0 | GO:0071380 | cellular response to prostaglandin E stimulus(GO:0071380) |
| 0.1 | 0.9 | GO:0048569 | post-embryonic organ development(GO:0048569) |
| 0.1 | 0.7 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
| 0.1 | 1.6 | GO:0098828 | positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
| 0.1 | 0.3 | GO:0042320 | regulation of circadian sleep/wake cycle, REM sleep(GO:0042320) |
| 0.1 | 0.3 | GO:0099590 | neurotransmitter receptor internalization(GO:0099590) |
| 0.1 | 0.2 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
| 0.1 | 0.4 | GO:0044571 | [2Fe-2S] cluster assembly(GO:0044571) |
| 0.1 | 0.6 | GO:0032218 | riboflavin transport(GO:0032218) |
| 0.1 | 0.6 | GO:0070316 | regulation of G0 to G1 transition(GO:0070316) |
| 0.1 | 0.6 | GO:0035583 | sequestering of TGFbeta in extracellular matrix(GO:0035583) |
| 0.1 | 1.4 | GO:0010592 | positive regulation of lamellipodium assembly(GO:0010592) |
| 0.1 | 1.4 | GO:0061001 | regulation of dendritic spine morphogenesis(GO:0061001) |
| 0.1 | 0.9 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
| 0.1 | 2.3 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
| 0.1 | 2.5 | GO:0006907 | pinocytosis(GO:0006907) |
| 0.1 | 0.5 | GO:0030421 | defecation(GO:0030421) |
| 0.1 | 0.9 | GO:0098734 | macromolecule depalmitoylation(GO:0098734) |
| 0.1 | 0.5 | GO:0006842 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
| 0.1 | 1.2 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
| 0.1 | 0.7 | GO:1903546 | receptor localization to nonmotile primary cilium(GO:0097500) protein localization to photoreceptor outer segment(GO:1903546) |
| 0.1 | 3.1 | GO:0034080 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
| 0.1 | 0.8 | GO:0098870 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
| 0.1 | 0.7 | GO:0010968 | regulation of microtubule nucleation(GO:0010968) |
| 0.1 | 0.3 | GO:0034163 | regulation of toll-like receptor 9 signaling pathway(GO:0034163) negative regulation of toll-like receptor 9 signaling pathway(GO:0034164) |
| 0.1 | 0.5 | GO:0010626 | regulation of Schwann cell proliferation(GO:0010624) negative regulation of Schwann cell proliferation(GO:0010626) |
| 0.1 | 0.2 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
| 0.1 | 0.1 | GO:0030573 | bile acid catabolic process(GO:0030573) |
| 0.1 | 0.7 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
| 0.1 | 0.4 | GO:0061152 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
| 0.1 | 0.4 | GO:0052697 | flavonoid glucuronidation(GO:0052696) xenobiotic glucuronidation(GO:0052697) |
| 0.1 | 0.6 | GO:0007144 | female meiosis I(GO:0007144) |
| 0.1 | 0.7 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
| 0.1 | 2.1 | GO:0014047 | glutamate secretion(GO:0014047) |
| 0.1 | 0.4 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
| 0.1 | 0.7 | GO:0042711 | maternal behavior(GO:0042711) parental behavior(GO:0060746) |
| 0.1 | 2.9 | GO:0006699 | bile acid biosynthetic process(GO:0006699) |
| 0.1 | 0.5 | GO:2000580 | regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000580) positive regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000582) |
| 0.1 | 0.4 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
| 0.1 | 1.7 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
| 0.1 | 0.5 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
| 0.1 | 0.1 | GO:0001827 | inner cell mass cell fate commitment(GO:0001827) |
| 0.1 | 0.6 | GO:0009253 | peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) |
| 0.1 | 0.3 | GO:1902255 | regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902162) positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902164) positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902255) |
| 0.1 | 1.0 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
| 0.1 | 0.6 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
| 0.1 | 0.8 | GO:0010744 | positive regulation of macrophage derived foam cell differentiation(GO:0010744) |
| 0.1 | 0.5 | GO:0002943 | tRNA dihydrouridine synthesis(GO:0002943) |
| 0.1 | 0.3 | GO:0051182 | coenzyme transport(GO:0051182) |
| 0.1 | 0.5 | GO:0006616 | SRP-dependent cotranslational protein targeting to membrane, translocation(GO:0006616) |
| 0.1 | 1.1 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
| 0.1 | 0.1 | GO:0003198 | epithelial to mesenchymal transition involved in endocardial cushion formation(GO:0003198) |
| 0.1 | 2.8 | GO:0043001 | Golgi to plasma membrane protein transport(GO:0043001) |
| 0.1 | 2.1 | GO:0033006 | regulation of mast cell activation involved in immune response(GO:0033006) regulation of mast cell degranulation(GO:0043304) |
| 0.1 | 0.3 | GO:0070307 | lens fiber cell development(GO:0070307) |
| 0.1 | 0.3 | GO:1903551 | regulation of extracellular exosome assembly(GO:1903551) |
| 0.1 | 0.8 | GO:0042262 | DNA protection(GO:0042262) |
| 0.1 | 0.3 | GO:0060449 | bud elongation involved in lung branching(GO:0060449) |
| 0.1 | 1.3 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
| 0.1 | 1.1 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
| 0.1 | 0.3 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
| 0.1 | 0.6 | GO:0034390 | smooth muscle cell apoptotic process(GO:0034390) regulation of smooth muscle cell apoptotic process(GO:0034391) |
| 0.1 | 0.2 | GO:0015766 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
| 0.1 | 0.2 | GO:0061582 | intestinal epithelial cell migration(GO:0061582) |
| 0.1 | 0.8 | GO:0002544 | chronic inflammatory response(GO:0002544) |
| 0.1 | 0.7 | GO:0010801 | negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
| 0.1 | 0.5 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
| 0.1 | 1.7 | GO:0070306 | lens fiber cell differentiation(GO:0070306) |
| 0.1 | 0.9 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
| 0.1 | 0.3 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
| 0.1 | 0.2 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
| 0.1 | 0.2 | GO:0042636 | negative regulation of hair cycle(GO:0042636) |
| 0.1 | 0.4 | GO:0044245 | polysaccharide digestion(GO:0044245) |
| 0.1 | 0.2 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
| 0.1 | 0.9 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
| 0.1 | 0.3 | GO:0002551 | mast cell chemotaxis(GO:0002551) regulation of mast cell chemotaxis(GO:0060753) positive regulation of mast cell chemotaxis(GO:0060754) |
| 0.1 | 0.7 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
| 0.1 | 0.2 | GO:1902952 | positive regulation of dendritic spine maintenance(GO:1902952) |
| 0.1 | 0.5 | GO:0010917 | negative regulation of mitochondrial membrane potential(GO:0010917) |
| 0.1 | 0.3 | GO:0035547 | interferon-beta secretion(GO:0035546) regulation of interferon-beta secretion(GO:0035547) |
| 0.1 | 0.4 | GO:0008050 | courtship behavior(GO:0007619) female courtship behavior(GO:0008050) |
| 0.1 | 0.3 | GO:0051001 | negative regulation of nitric-oxide synthase activity(GO:0051001) |
| 0.1 | 0.3 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
| 0.1 | 6.0 | GO:0030216 | keratinocyte differentiation(GO:0030216) |
| 0.1 | 0.3 | GO:1904058 | positive regulation of sensory perception of pain(GO:1904058) |
| 0.1 | 0.3 | GO:0061051 | positive regulation of cell growth involved in cardiac muscle cell development(GO:0061051) |
| 0.1 | 3.8 | GO:0046426 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
| 0.1 | 0.6 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
| 0.1 | 0.3 | GO:0071918 | urea transmembrane transport(GO:0071918) |
| 0.1 | 3.4 | GO:2000177 | regulation of neural precursor cell proliferation(GO:2000177) |
| 0.1 | 0.8 | GO:0008212 | mineralocorticoid biosynthetic process(GO:0006705) mineralocorticoid metabolic process(GO:0008212) |
| 0.1 | 0.5 | GO:0030728 | ovulation(GO:0030728) |
| 0.1 | 1.5 | GO:0000732 | strand displacement(GO:0000732) |
| 0.1 | 0.5 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
| 0.1 | 0.2 | GO:0034374 | low-density lipoprotein particle remodeling(GO:0034374) |
| 0.1 | 0.6 | GO:0006449 | regulation of translational termination(GO:0006449) |
| 0.1 | 0.2 | GO:0071442 | regulation of histone H3-K14 acetylation(GO:0071440) positive regulation of histone H3-K14 acetylation(GO:0071442) |
| 0.1 | 0.2 | GO:0014057 | positive regulation of acetylcholine secretion, neurotransmission(GO:0014057) |
| 0.1 | 0.9 | GO:0070542 | response to fatty acid(GO:0070542) |
| 0.1 | 0.6 | GO:0042340 | keratan sulfate catabolic process(GO:0042340) |
| 0.1 | 1.0 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
| 0.1 | 6.4 | GO:0015718 | monocarboxylic acid transport(GO:0015718) |
| 0.1 | 0.6 | GO:0030091 | protein repair(GO:0030091) |
| 0.1 | 0.6 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
| 0.1 | 4.5 | GO:0002062 | chondrocyte differentiation(GO:0002062) |
| 0.1 | 0.2 | GO:0042946 | glucoside transport(GO:0042946) |
| 0.1 | 2.9 | GO:0050994 | regulation of lipid catabolic process(GO:0050994) |
| 0.1 | 0.5 | GO:0020027 | hemoglobin metabolic process(GO:0020027) |
| 0.0 | 0.2 | GO:0046498 | S-adenosylhomocysteine metabolic process(GO:0046498) |
| 0.0 | 0.3 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
| 0.0 | 1.2 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
| 0.0 | 0.4 | GO:0015811 | L-cystine transport(GO:0015811) |
| 0.0 | 0.3 | GO:0000380 | alternative mRNA splicing, via spliceosome(GO:0000380) |
| 0.0 | 1.7 | GO:0072488 | ammonium transmembrane transport(GO:0072488) |
| 0.0 | 1.1 | GO:0005513 | detection of calcium ion(GO:0005513) |
| 0.0 | 0.4 | GO:0006662 | glycerol ether metabolic process(GO:0006662) |
| 0.0 | 2.4 | GO:0051496 | positive regulation of stress fiber assembly(GO:0051496) |
| 0.0 | 8.0 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
| 0.0 | 0.6 | GO:0043486 | histone exchange(GO:0043486) |
| 0.0 | 0.8 | GO:0071398 | cellular response to fatty acid(GO:0071398) |
| 0.0 | 1.3 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
| 0.0 | 0.2 | GO:0046689 | response to mercury ion(GO:0046689) |
| 0.0 | 0.5 | GO:0035635 | entry of bacterium into host cell(GO:0035635) |
| 0.0 | 1.5 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
| 0.0 | 0.2 | GO:0051451 | myoblast migration(GO:0051451) |
| 0.0 | 0.2 | GO:0072366 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter(GO:0072366) |
| 0.0 | 1.2 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
| 0.0 | 0.5 | GO:0016242 | negative regulation of macroautophagy(GO:0016242) |
| 0.0 | 0.4 | GO:0051418 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
| 0.0 | 2.2 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
| 0.0 | 0.4 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
| 0.0 | 0.6 | GO:0006700 | C21-steroid hormone biosynthetic process(GO:0006700) |
| 0.0 | 1.3 | GO:0071539 | protein localization to centrosome(GO:0071539) |
| 0.0 | 0.6 | GO:0046628 | positive regulation of insulin receptor signaling pathway(GO:0046628) |
| 0.0 | 0.7 | GO:0044380 | protein localization to cytoskeleton(GO:0044380) |
| 0.0 | 0.2 | GO:2000312 | regulation of kainate selective glutamate receptor activity(GO:2000312) |
| 0.0 | 3.5 | GO:0000079 | regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0000079) |
| 0.0 | 0.3 | GO:0070459 | prolactin secretion(GO:0070459) |
| 0.0 | 0.8 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
| 0.0 | 1.7 | GO:0030834 | regulation of actin filament depolymerization(GO:0030834) |
| 0.0 | 1.2 | GO:0007194 | negative regulation of adenylate cyclase activity(GO:0007194) |
| 0.0 | 1.0 | GO:0043278 | response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
| 0.0 | 1.1 | GO:0021680 | cerebellar Purkinje cell layer development(GO:0021680) |
| 0.0 | 1.6 | GO:1902400 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) signal transduction involved in mitotic cell cycle checkpoint(GO:0072413) signal transduction involved in mitotic G1 DNA damage checkpoint(GO:0072431) intracellular signal transduction involved in G1 DNA damage checkpoint(GO:1902400) signal transduction involved in mitotic DNA damage checkpoint(GO:1902402) signal transduction involved in mitotic DNA integrity checkpoint(GO:1902403) |
| 0.0 | 3.2 | GO:0046847 | filopodium assembly(GO:0046847) |
| 0.0 | 0.1 | GO:1901053 | sarcosine metabolic process(GO:1901052) sarcosine catabolic process(GO:1901053) |
| 0.0 | 1.2 | GO:0000717 | nucleotide-excision repair, DNA duplex unwinding(GO:0000717) |
| 0.0 | 0.2 | GO:0046166 | glyceraldehyde-3-phosphate biosynthetic process(GO:0046166) |
| 0.0 | 1.4 | GO:0032508 | DNA duplex unwinding(GO:0032508) |
| 0.0 | 1.0 | GO:0051353 | positive regulation of oxidoreductase activity(GO:0051353) |
| 0.0 | 2.7 | GO:0051865 | protein autoubiquitination(GO:0051865) |
| 0.0 | 0.6 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) sphingolipid mediated signaling pathway(GO:0090520) |
| 0.0 | 0.3 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
| 0.0 | 0.2 | GO:0036150 | phosphatidylserine acyl-chain remodeling(GO:0036150) |
| 0.0 | 1.2 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
| 0.0 | 0.2 | GO:1903301 | positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
| 0.0 | 0.2 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
| 0.0 | 0.1 | GO:0070898 | RNA polymerase III transcriptional preinitiation complex assembly(GO:0070898) |
| 0.0 | 0.2 | GO:1900016 | negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
| 0.0 | 0.5 | GO:0030252 | growth hormone secretion(GO:0030252) |
| 0.0 | 4.6 | GO:0007030 | Golgi organization(GO:0007030) |
| 0.0 | 0.3 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
| 0.0 | 0.5 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
| 0.0 | 0.2 | GO:0043606 | histidine catabolic process to glutamate and formamide(GO:0019556) histidine catabolic process to glutamate and formate(GO:0019557) formamide metabolic process(GO:0043606) |
| 0.0 | 0.5 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
| 0.0 | 1.0 | GO:1904659 | hexose transmembrane transport(GO:0035428) glucose transmembrane transport(GO:1904659) |
| 0.0 | 0.8 | GO:1900087 | positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) |
| 0.0 | 0.4 | GO:0050872 | white fat cell differentiation(GO:0050872) |
| 0.0 | 0.3 | GO:0048266 | behavioral response to pain(GO:0048266) |
| 0.0 | 1.4 | GO:0003281 | ventricular septum development(GO:0003281) |
| 0.0 | 0.7 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
| 0.0 | 0.3 | GO:0035984 | primary heart field specification(GO:0003138) sinoatrial valve development(GO:0003172) sinoatrial valve morphogenesis(GO:0003185) positive regulation of myeloid cell apoptotic process(GO:0033034) response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) positive regulation of macrophage apoptotic process(GO:2000111) |
| 0.0 | 0.1 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
| 0.0 | 6.0 | GO:0051321 | meiotic cell cycle(GO:0051321) |
| 0.0 | 1.4 | GO:0033260 | nuclear DNA replication(GO:0033260) |
| 0.0 | 0.5 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
| 0.0 | 0.2 | GO:0061737 | leukotriene signaling pathway(GO:0061737) |
| 0.0 | 0.8 | GO:0031640 | killing of cells of other organism(GO:0031640) disruption of cells of other organism(GO:0044364) |
| 0.0 | 0.2 | GO:0042908 | xenobiotic transport(GO:0042908) |
| 0.0 | 0.9 | GO:0008334 | histone mRNA metabolic process(GO:0008334) |
| 0.0 | 0.5 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
| 0.0 | 0.3 | GO:0006108 | malate metabolic process(GO:0006108) |
| 0.0 | 0.5 | GO:0045776 | negative regulation of blood pressure(GO:0045776) |
| 0.0 | 0.5 | GO:0006893 | Golgi to plasma membrane transport(GO:0006893) |
| 0.0 | 0.5 | GO:0006688 | glycosphingolipid biosynthetic process(GO:0006688) |
| 0.0 | 0.3 | GO:0021575 | hindbrain morphogenesis(GO:0021575) |
| 0.0 | 0.2 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
| 0.0 | 3.5 | GO:0007062 | sister chromatid cohesion(GO:0007062) |
| 0.0 | 0.4 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
| 0.0 | 0.9 | GO:0043574 | protein targeting to peroxisome(GO:0006625) peroxisomal transport(GO:0043574) protein localization to peroxisome(GO:0072662) establishment of protein localization to peroxisome(GO:0072663) |
| 0.0 | 0.2 | GO:1902166 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902166) |
| 0.0 | 0.2 | GO:0034227 | tRNA thio-modification(GO:0034227) |
| 0.0 | 1.2 | GO:0016574 | histone ubiquitination(GO:0016574) |
| 0.0 | 0.4 | GO:0060444 | branching involved in mammary gland duct morphogenesis(GO:0060444) |
| 0.0 | 0.3 | GO:0045109 | intermediate filament organization(GO:0045109) |
| 0.0 | 0.4 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
| 0.0 | 0.4 | GO:0070911 | global genome nucleotide-excision repair(GO:0070911) |
| 0.0 | 0.2 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
| 0.0 | 0.4 | GO:0019317 | fucose catabolic process(GO:0019317) L-fucose metabolic process(GO:0042354) L-fucose catabolic process(GO:0042355) |
| 0.0 | 1.6 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
| 0.0 | 0.3 | GO:0060340 | positive regulation of type I interferon-mediated signaling pathway(GO:0060340) |
| 0.0 | 0.1 | GO:0010888 | negative regulation of lipid storage(GO:0010888) |
| 0.0 | 0.9 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
| 0.0 | 0.4 | GO:1904380 | endoplasmic reticulum mannose trimming(GO:1904380) |
| 0.0 | 1.0 | GO:0071300 | cellular response to retinoic acid(GO:0071300) |
| 0.0 | 1.1 | GO:0008038 | neuron recognition(GO:0008038) |
| 0.0 | 0.3 | GO:0098743 | cell aggregation(GO:0098743) |
| 0.0 | 2.5 | GO:0051017 | actin filament bundle assembly(GO:0051017) |
| 0.0 | 0.3 | GO:0010762 | regulation of fibroblast migration(GO:0010762) |
| 0.0 | 0.2 | GO:1900112 | regulation of histone H3-K9 trimethylation(GO:1900112) |
| 0.0 | 0.1 | GO:1901534 | positive regulation of megakaryocyte differentiation(GO:0045654) positive regulation of hematopoietic progenitor cell differentiation(GO:1901534) |
| 0.0 | 0.2 | GO:0060742 | epithelial cell differentiation involved in prostate gland development(GO:0060742) |
| 0.0 | 1.1 | GO:0070527 | platelet aggregation(GO:0070527) |
| 0.0 | 0.2 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
| 0.0 | 0.2 | GO:0001569 | patterning of blood vessels(GO:0001569) |
| 0.0 | 0.2 | GO:0043923 | positive regulation by host of viral transcription(GO:0043923) |
| 0.0 | 1.2 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
| 0.0 | 1.4 | GO:0034332 | adherens junction organization(GO:0034332) |
| 0.0 | 0.5 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
| 0.0 | 0.3 | GO:0001682 | tRNA 5'-leader removal(GO:0001682) |
| 0.0 | 0.2 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
| 0.0 | 0.2 | GO:0006561 | proline biosynthetic process(GO:0006561) |
| 0.0 | 0.1 | GO:1903244 | positive regulation of cardiac muscle adaptation(GO:0010615) positive regulation of muscle adaptation(GO:0014744) positive regulation of cardiac muscle hypertrophy in response to stress(GO:1903244) |
| 0.0 | 0.3 | GO:1904355 | positive regulation of telomere capping(GO:1904355) |
| 0.0 | 4.0 | GO:0043484 | regulation of RNA splicing(GO:0043484) |
| 0.0 | 0.3 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
| 0.0 | 0.2 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
| 0.0 | 2.1 | GO:0051262 | protein tetramerization(GO:0051262) |
| 0.0 | 0.1 | GO:0009048 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
| 0.0 | 0.2 | GO:0048003 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
| 0.0 | 0.6 | GO:0035338 | long-chain fatty-acyl-CoA biosynthetic process(GO:0035338) |
| 0.0 | 0.1 | GO:0051121 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
| 0.0 | 0.6 | GO:0019933 | cAMP-mediated signaling(GO:0019933) |
| 0.0 | 0.9 | GO:0006198 | cAMP catabolic process(GO:0006198) |
| 0.0 | 0.3 | GO:0061014 | positive regulation of mRNA catabolic process(GO:0061014) |
| 0.0 | 0.6 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
| 0.0 | 0.2 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
| 0.0 | 0.0 | GO:0035771 | interleukin-4-mediated signaling pathway(GO:0035771) |
| 0.0 | 1.4 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
| 0.0 | 0.8 | GO:0032873 | negative regulation of stress-activated MAPK cascade(GO:0032873) negative regulation of stress-activated protein kinase signaling cascade(GO:0070303) |
| 0.0 | 0.2 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
| 0.0 | 0.2 | GO:0097320 | membrane tubulation(GO:0097320) |
| 0.0 | 0.1 | GO:0042670 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
| 0.0 | 0.8 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
| 0.0 | 0.8 | GO:0097345 | mitochondrial outer membrane permeabilization(GO:0097345) |
| 0.0 | 2.0 | GO:0038096 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis(GO:0002433) Fc-gamma receptor signaling pathway involved in phagocytosis(GO:0038096) |
| 0.0 | 0.1 | GO:0046968 | peptide antigen transport(GO:0046968) |
| 0.0 | 0.2 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
| 0.0 | 1.5 | GO:0030509 | BMP signaling pathway(GO:0030509) |
| 0.0 | 0.1 | GO:0045625 | regulation of T-helper 1 cell differentiation(GO:0045625) |
| 0.0 | 1.5 | GO:0046718 | entry into host cell(GO:0030260) entry into host(GO:0044409) viral entry into host cell(GO:0046718) entry into cell of other organism involved in symbiotic interaction(GO:0051806) entry into other organism involved in symbiotic interaction(GO:0051828) |
| 0.0 | 0.7 | GO:0045026 | plasma membrane fusion(GO:0045026) |
| 0.0 | 0.1 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
| 0.0 | 0.6 | GO:0000271 | polysaccharide biosynthetic process(GO:0000271) |
| 0.0 | 0.2 | GO:0014029 | neural crest formation(GO:0014029) |
| 0.0 | 0.1 | GO:0045040 | protein import into mitochondrial outer membrane(GO:0045040) |
| 0.0 | 0.2 | GO:0070828 | heterochromatin organization(GO:0070828) |
| 0.0 | 0.5 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
| 0.0 | 0.2 | GO:0072673 | lamellipodium morphogenesis(GO:0072673) |
| 0.0 | 0.1 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
| 0.0 | 0.5 | GO:0006195 | purine nucleotide catabolic process(GO:0006195) |
| 0.0 | 1.6 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
| 0.0 | 1.1 | GO:0046330 | positive regulation of JNK cascade(GO:0046330) |
| 0.0 | 0.2 | GO:0007202 | activation of phospholipase C activity(GO:0007202) |
| 0.0 | 0.5 | GO:0030101 | natural killer cell activation(GO:0030101) |
| 0.0 | 0.2 | GO:0072619 | interleukin-21 production(GO:0032625) interleukin-21 secretion(GO:0072619) |
| 0.0 | 0.5 | GO:1901222 | regulation of NIK/NF-kappaB signaling(GO:1901222) |
| 0.0 | 0.1 | GO:0045604 | regulation of epidermal cell differentiation(GO:0045604) |
| 0.0 | 0.5 | GO:0009247 | glycolipid biosynthetic process(GO:0009247) |
| 0.0 | 0.2 | GO:0006491 | N-glycan processing(GO:0006491) |
| 0.0 | 0.2 | GO:0006303 | double-strand break repair via nonhomologous end joining(GO:0006303) |
| 0.0 | 0.1 | GO:0071354 | cellular response to interleukin-6(GO:0071354) |
Gene overrepresentation in cellular component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 2.5 | 14.7 | GO:0097149 | centralspindlin complex(GO:0097149) |
| 2.0 | 14.1 | GO:0097209 | epidermal lamellar body(GO:0097209) |
| 2.0 | 13.9 | GO:0005610 | laminin-5 complex(GO:0005610) |
| 1.3 | 25.8 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
| 1.2 | 7.3 | GO:0031262 | Ndc80 complex(GO:0031262) |
| 0.9 | 52.3 | GO:0001533 | cornified envelope(GO:0001533) |
| 0.7 | 2.2 | GO:0033150 | cytoskeletal calyx(GO:0033150) |
| 0.7 | 2.9 | GO:0005889 | hydrogen:potassium-exchanging ATPase complex(GO:0005889) |
| 0.7 | 6.5 | GO:0071144 | SMAD2-SMAD3 protein complex(GO:0071144) |
| 0.7 | 3.5 | GO:0032449 | CBM complex(GO:0032449) |
| 0.7 | 3.3 | GO:0043256 | laminin complex(GO:0043256) |
| 0.7 | 3.3 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
| 0.6 | 2.2 | GO:0034669 | integrin alpha4-beta7 complex(GO:0034669) |
| 0.6 | 0.6 | GO:0034681 | integrin alpha11-beta1 complex(GO:0034681) |
| 0.5 | 2.1 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
| 0.5 | 9.3 | GO:0008091 | spectrin(GO:0008091) |
| 0.5 | 2.4 | GO:0036502 | Derlin-1-VIMP complex(GO:0036502) |
| 0.5 | 8.7 | GO:0032426 | stereocilium tip(GO:0032426) |
| 0.5 | 11.0 | GO:0097342 | ripoptosome(GO:0097342) |
| 0.5 | 2.8 | GO:0030934 | anchoring collagen complex(GO:0030934) |
| 0.4 | 1.3 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
| 0.4 | 1.3 | GO:0055028 | cortical microtubule(GO:0055028) |
| 0.4 | 1.8 | GO:0020003 | symbiont-containing vacuole(GO:0020003) |
| 0.4 | 1.6 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
| 0.4 | 1.9 | GO:0045160 | myosin I complex(GO:0045160) |
| 0.4 | 1.5 | GO:0000811 | GINS complex(GO:0000811) |
| 0.4 | 4.3 | GO:0036454 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
| 0.3 | 1.7 | GO:0071942 | XPC complex(GO:0071942) |
| 0.3 | 1.0 | GO:0033565 | ESCRT-0 complex(GO:0033565) |
| 0.3 | 2.5 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
| 0.3 | 1.5 | GO:1990425 | ryanodine receptor complex(GO:1990425) |
| 0.3 | 1.2 | GO:0042720 | mitochondrial inner membrane peptidase complex(GO:0042720) |
| 0.3 | 4.4 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
| 0.3 | 1.7 | GO:0071458 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) |
| 0.3 | 2.8 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
| 0.3 | 3.1 | GO:0035692 | macrophage migration inhibitory factor receptor complex(GO:0035692) |
| 0.3 | 0.8 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
| 0.3 | 0.8 | GO:0034515 | proteasome storage granule(GO:0034515) |
| 0.3 | 3.8 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
| 0.3 | 0.8 | GO:0071065 | alpha9-beta1 integrin-vascular cell adhesion molecule-1 complex(GO:0071065) |
| 0.3 | 10.6 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
| 0.2 | 0.7 | GO:0051286 | growing cell tip(GO:0035838) new growing cell tip(GO:0035841) cell tip(GO:0051286) |
| 0.2 | 0.9 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
| 0.2 | 1.6 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
| 0.2 | 19.5 | GO:1904724 | tertiary granule lumen(GO:1904724) |
| 0.2 | 1.1 | GO:1990031 | pinceau fiber(GO:1990031) |
| 0.2 | 0.9 | GO:0097229 | sperm end piece(GO:0097229) |
| 0.2 | 2.1 | GO:0005787 | signal peptidase complex(GO:0005787) |
| 0.2 | 1.9 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
| 0.2 | 0.6 | GO:0097598 | sperm cytoplasmic droplet(GO:0097598) |
| 0.2 | 0.6 | GO:0019031 | viral envelope(GO:0019031) viral membrane(GO:0036338) |
| 0.2 | 1.4 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
| 0.2 | 3.0 | GO:0030478 | actin cap(GO:0030478) |
| 0.2 | 0.6 | GO:0097013 | phagocytic vesicle lumen(GO:0097013) |
| 0.2 | 1.3 | GO:0033503 | HULC complex(GO:0033503) |
| 0.2 | 2.8 | GO:0071438 | invadopodium membrane(GO:0071438) |
| 0.2 | 0.7 | GO:0000839 | Hrd1p ubiquitin ligase ERAD-L complex(GO:0000839) |
| 0.2 | 4.1 | GO:0030056 | hemidesmosome(GO:0030056) |
| 0.2 | 4.1 | GO:0043205 | microfibril(GO:0001527) fibril(GO:0043205) |
| 0.2 | 2.5 | GO:0032433 | filopodium tip(GO:0032433) |
| 0.2 | 1.0 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
| 0.2 | 6.9 | GO:0031430 | M band(GO:0031430) |
| 0.2 | 1.8 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
| 0.2 | 0.8 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
| 0.2 | 1.7 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
| 0.2 | 2.2 | GO:0071437 | invadopodium(GO:0071437) |
| 0.2 | 0.9 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
| 0.2 | 7.8 | GO:0043034 | costamere(GO:0043034) |
| 0.2 | 0.5 | GO:0097524 | sperm plasma membrane(GO:0097524) |
| 0.1 | 0.4 | GO:0032002 | interleukin-28 receptor complex(GO:0032002) |
| 0.1 | 0.6 | GO:0005927 | muscle tendon junction(GO:0005927) |
| 0.1 | 4.4 | GO:0035371 | microtubule plus-end(GO:0035371) |
| 0.1 | 1.2 | GO:0005827 | polar microtubule(GO:0005827) |
| 0.1 | 1.0 | GO:0070436 | Grb2-EGFR complex(GO:0070436) |
| 0.1 | 2.0 | GO:0032797 | SMN complex(GO:0032797) |
| 0.1 | 1.7 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
| 0.1 | 0.7 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
| 0.1 | 0.5 | GO:0033257 | Bcl3/NF-kappaB2 complex(GO:0033257) |
| 0.1 | 3.2 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
| 0.1 | 0.4 | GO:0072563 | endothelial microparticle(GO:0072563) |
| 0.1 | 1.4 | GO:0042587 | glycogen granule(GO:0042587) |
| 0.1 | 3.2 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
| 0.1 | 16.9 | GO:0035578 | azurophil granule lumen(GO:0035578) |
| 0.1 | 0.8 | GO:0030868 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
| 0.1 | 2.9 | GO:0005719 | nuclear euchromatin(GO:0005719) |
| 0.1 | 1.0 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
| 0.1 | 3.3 | GO:0001891 | phagocytic cup(GO:0001891) |
| 0.1 | 0.3 | GO:0071148 | TEAD-1-YAP complex(GO:0071148) |
| 0.1 | 0.5 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
| 0.1 | 1.8 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
| 0.1 | 17.8 | GO:0005882 | intermediate filament(GO:0005882) |
| 0.1 | 0.4 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
| 0.1 | 13.3 | GO:0005604 | basement membrane(GO:0005604) |
| 0.1 | 4.0 | GO:0002102 | podosome(GO:0002102) |
| 0.1 | 1.0 | GO:0031045 | dense core granule(GO:0031045) |
| 0.1 | 0.7 | GO:0045179 | apical cortex(GO:0045179) |
| 0.1 | 0.4 | GO:0000126 | transcription factor TFIIIB complex(GO:0000126) |
| 0.1 | 1.0 | GO:0097486 | multivesicular body lumen(GO:0097486) |
| 0.1 | 3.6 | GO:0043202 | lysosomal lumen(GO:0043202) |
| 0.1 | 1.7 | GO:0000800 | lateral element(GO:0000800) |
| 0.1 | 1.7 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
| 0.1 | 2.5 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
| 0.1 | 0.7 | GO:0030057 | desmosome(GO:0030057) |
| 0.1 | 3.8 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
| 0.1 | 1.3 | GO:0001741 | XY body(GO:0001741) |
| 0.1 | 9.8 | GO:0034774 | secretory granule lumen(GO:0034774) |
| 0.1 | 7.0 | GO:0030315 | T-tubule(GO:0030315) |
| 0.1 | 3.1 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
| 0.1 | 0.7 | GO:0017059 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
| 0.1 | 0.5 | GO:0043541 | UDP-N-acetylglucosamine transferase complex(GO:0043541) |
| 0.1 | 0.8 | GO:0070187 | telosome(GO:0070187) |
| 0.1 | 1.1 | GO:0019774 | proteasome core complex, beta-subunit complex(GO:0019774) |
| 0.1 | 0.4 | GO:0005854 | nascent polypeptide-associated complex(GO:0005854) |
| 0.1 | 0.4 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
| 0.1 | 1.3 | GO:0042589 | zymogen granule membrane(GO:0042589) |
| 0.1 | 0.7 | GO:0097452 | GAIT complex(GO:0097452) |
| 0.1 | 19.6 | GO:0001726 | ruffle(GO:0001726) |
| 0.1 | 5.8 | GO:0055038 | recycling endosome membrane(GO:0055038) |
| 0.1 | 1.0 | GO:0005915 | zonula adherens(GO:0005915) |
| 0.1 | 0.8 | GO:0046581 | intercellular canaliculus(GO:0046581) |
| 0.1 | 7.3 | GO:0005581 | collagen trimer(GO:0005581) |
| 0.1 | 1.9 | GO:0033202 | Ino80 complex(GO:0031011) DNA helicase complex(GO:0033202) |
| 0.1 | 1.5 | GO:0010369 | chromocenter(GO:0010369) |
| 0.1 | 0.3 | GO:0097165 | perichromatin fibrils(GO:0005726) nuclear stress granule(GO:0097165) |
| 0.1 | 0.5 | GO:0032059 | bleb(GO:0032059) |
| 0.1 | 0.9 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
| 0.1 | 1.3 | GO:0005686 | U2 snRNP(GO:0005686) |
| 0.1 | 7.4 | GO:0042734 | presynaptic membrane(GO:0042734) |
| 0.1 | 1.1 | GO:0014704 | intercalated disc(GO:0014704) |
| 0.1 | 0.8 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
| 0.1 | 0.8 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
| 0.1 | 0.6 | GO:0016461 | unconventional myosin complex(GO:0016461) |
| 0.1 | 1.8 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
| 0.1 | 3.4 | GO:0048786 | presynaptic active zone(GO:0048786) |
| 0.1 | 1.0 | GO:0042555 | MCM complex(GO:0042555) |
| 0.1 | 5.1 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
| 0.1 | 8.3 | GO:0031985 | Golgi cisterna(GO:0031985) |
| 0.1 | 0.5 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
| 0.1 | 7.0 | GO:0005796 | Golgi lumen(GO:0005796) |
| 0.1 | 0.3 | GO:0043564 | Ku70:Ku80 complex(GO:0043564) |
| 0.1 | 0.9 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
| 0.1 | 0.5 | GO:0031258 | lamellipodium membrane(GO:0031258) |
| 0.1 | 0.2 | GO:0017102 | methionyl glutamyl tRNA synthetase complex(GO:0017102) |
| 0.1 | 6.8 | GO:0035579 | specific granule membrane(GO:0035579) |
| 0.1 | 10.2 | GO:0031225 | anchored component of membrane(GO:0031225) |
| 0.1 | 1.4 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
| 0.1 | 0.4 | GO:0033165 | interphotoreceptor matrix(GO:0033165) |
| 0.1 | 1.0 | GO:0032591 | dendritic spine membrane(GO:0032591) |
| 0.1 | 2.1 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
| 0.1 | 0.4 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
| 0.0 | 0.2 | GO:0017109 | glutamate-cysteine ligase complex(GO:0017109) |
| 0.0 | 3.9 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
| 0.0 | 0.4 | GO:0001520 | outer dense fiber(GO:0001520) |
| 0.0 | 1.2 | GO:0005922 | connexon complex(GO:0005922) |
| 0.0 | 1.1 | GO:0000242 | pericentriolar material(GO:0000242) |
| 0.0 | 0.2 | GO:0061617 | MICOS complex(GO:0061617) |
| 0.0 | 0.2 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
| 0.0 | 0.2 | GO:0045273 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
| 0.0 | 0.7 | GO:0031414 | N-terminal protein acetyltransferase complex(GO:0031414) |
| 0.0 | 0.2 | GO:0032807 | DNA ligase IV complex(GO:0032807) |
| 0.0 | 0.4 | GO:0033268 | node of Ranvier(GO:0033268) |
| 0.0 | 0.3 | GO:0097443 | sorting endosome(GO:0097443) |
| 0.0 | 1.3 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
| 0.0 | 0.2 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
| 0.0 | 0.5 | GO:0072546 | ER membrane protein complex(GO:0072546) |
| 0.0 | 0.1 | GO:0001674 | female germ cell nucleus(GO:0001674) |
| 0.0 | 0.3 | GO:0098563 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
| 0.0 | 0.5 | GO:0032585 | multivesicular body membrane(GO:0032585) |
| 0.0 | 1.1 | GO:0034451 | centriolar satellite(GO:0034451) |
| 0.0 | 0.5 | GO:0000815 | ESCRT III complex(GO:0000815) |
| 0.0 | 0.5 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
| 0.0 | 0.2 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
| 0.0 | 0.7 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
| 0.0 | 3.5 | GO:0005901 | caveola(GO:0005901) |
| 0.0 | 0.1 | GO:0031906 | late endosome lumen(GO:0031906) |
| 0.0 | 1.6 | GO:0005876 | spindle microtubule(GO:0005876) |
| 0.0 | 0.4 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
| 0.0 | 0.3 | GO:0045298 | tubulin complex(GO:0045298) |
| 0.0 | 0.5 | GO:0032039 | integrator complex(GO:0032039) |
| 0.0 | 7.5 | GO:0000793 | condensed chromosome(GO:0000793) |
| 0.0 | 0.3 | GO:0005577 | fibrinogen complex(GO:0005577) |
| 0.0 | 0.8 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
| 0.0 | 1.9 | GO:0035577 | azurophil granule membrane(GO:0035577) |
| 0.0 | 8.8 | GO:0005819 | spindle(GO:0005819) |
| 0.0 | 1.2 | GO:0097610 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
| 0.0 | 3.1 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
| 0.0 | 1.7 | GO:0005902 | microvillus(GO:0005902) |
| 0.0 | 1.2 | GO:0043198 | dendritic shaft(GO:0043198) |
| 0.0 | 1.5 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
| 0.0 | 0.2 | GO:0030905 | retromer, tubulation complex(GO:0030905) |
| 0.0 | 0.2 | GO:0098839 | postsynaptic density membrane(GO:0098839) |
| 0.0 | 0.4 | GO:0097346 | INO80-type complex(GO:0097346) |
| 0.0 | 3.7 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
| 0.0 | 0.1 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
| 0.0 | 0.3 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) |
| 0.0 | 0.1 | GO:0005960 | glycine cleavage complex(GO:0005960) |
| 0.0 | 34.8 | GO:0005615 | extracellular space(GO:0005615) |
| 0.0 | 0.5 | GO:0005639 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
| 0.0 | 0.7 | GO:0031941 | filamentous actin(GO:0031941) |
| 0.0 | 0.1 | GO:0071547 | piP-body(GO:0071547) |
| 0.0 | 0.3 | GO:0033391 | chromatoid body(GO:0033391) |
| 0.0 | 3.3 | GO:0030667 | secretory granule membrane(GO:0030667) |
| 0.0 | 1.0 | GO:0070821 | tertiary granule membrane(GO:0070821) |
| 0.0 | 0.3 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
| 0.0 | 0.5 | GO:0044232 | organelle membrane contact site(GO:0044232) |
| 0.0 | 2.6 | GO:0043197 | dendritic spine(GO:0043197) |
| 0.0 | 1.3 | GO:0005637 | nuclear inner membrane(GO:0005637) |
| 0.0 | 0.3 | GO:0030008 | TRAPP complex(GO:0030008) |
| 0.0 | 0.2 | GO:0070531 | BRCA1-A complex(GO:0070531) |
| 0.0 | 0.2 | GO:0043194 | axon initial segment(GO:0043194) |
| 0.0 | 0.1 | GO:0001652 | granular component(GO:0001652) |
| 0.0 | 0.8 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
| 0.0 | 0.3 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
| 0.0 | 0.3 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
| 0.0 | 8.2 | GO:0031012 | extracellular matrix(GO:0031012) |
| 0.0 | 0.3 | GO:0043220 | Schmidt-Lanterman incisure(GO:0043220) |
| 0.0 | 0.1 | GO:0097427 | microtubule bundle(GO:0097427) |
| 0.0 | 0.8 | GO:0031526 | brush border membrane(GO:0031526) |
| 0.0 | 1.2 | GO:0005905 | clathrin-coated pit(GO:0005905) |
| 0.0 | 0.3 | GO:0031083 | BLOC-1 complex(GO:0031083) |
| 0.0 | 6.3 | GO:0005925 | focal adhesion(GO:0005925) |
| 0.0 | 3.7 | GO:0031968 | organelle outer membrane(GO:0031968) |
| 0.0 | 0.3 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
| 0.0 | 1.4 | GO:0034707 | chloride channel complex(GO:0034707) |
| 0.0 | 0.2 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
| 0.0 | 0.2 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
| 0.0 | 0.0 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
| 0.0 | 1.8 | GO:0045211 | postsynaptic membrane(GO:0045211) |
| 0.0 | 0.3 | GO:1904115 | axon cytoplasm(GO:1904115) |
| 0.0 | 0.1 | GO:1904813 | ficolin-1-rich granule(GO:0101002) ficolin-1-rich granule lumen(GO:1904813) |
Gene overrepresentation in molecular function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 4.2 | 12.7 | GO:0004850 | uridine phosphorylase activity(GO:0004850) |
| 3.5 | 24.8 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
| 1.6 | 7.9 | GO:0005152 | interleukin-1 receptor antagonist activity(GO:0005152) |
| 1.5 | 4.5 | GO:0031731 | CCR6 chemokine receptor binding(GO:0031731) |
| 1.2 | 4.6 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) indanol dehydrogenase activity(GO:0047718) |
| 1.1 | 22.8 | GO:0050786 | RAGE receptor binding(GO:0050786) |
| 1.1 | 3.2 | GO:0036487 | nitric-oxide synthase inhibitor activity(GO:0036487) |
| 1.1 | 7.5 | GO:0034617 | tetrahydrobiopterin binding(GO:0034617) |
| 1.1 | 6.5 | GO:0031962 | mineralocorticoid receptor binding(GO:0031962) |
| 1.0 | 17.6 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
| 1.0 | 4.9 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
| 1.0 | 2.9 | GO:0030290 | sphingolipid activator protein activity(GO:0030290) beta-N-acetylgalactosaminidase activity(GO:0032428) |
| 1.0 | 2.9 | GO:0002113 | interleukin-33 binding(GO:0002113) |
| 0.9 | 2.6 | GO:0070119 | ciliary neurotrophic factor binding(GO:0070119) |
| 0.9 | 2.6 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
| 0.8 | 5.8 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
| 0.8 | 3.3 | GO:0002060 | purine nucleobase binding(GO:0002060) |
| 0.8 | 4.8 | GO:0017161 | phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity(GO:0016316) inositol-1,3,4-trisphosphate 4-phosphatase activity(GO:0017161) phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity(GO:0034597) inositol-3,4-bisphosphate 4-phosphatase activity(GO:0052828) |
| 0.8 | 8.3 | GO:0042731 | PH domain binding(GO:0042731) |
| 0.7 | 4.3 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
| 0.7 | 9.2 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
| 0.7 | 4.1 | GO:1990254 | keratin filament binding(GO:1990254) |
| 0.7 | 3.3 | GO:0016728 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
| 0.6 | 9.1 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
| 0.6 | 1.9 | GO:0033878 | hormone-sensitive lipase activity(GO:0033878) |
| 0.6 | 3.2 | GO:0030395 | lactose binding(GO:0030395) |
| 0.6 | 4.5 | GO:0008481 | sphinganine kinase activity(GO:0008481) D-erythro-sphingosine kinase activity(GO:0017050) |
| 0.6 | 1.9 | GO:0008457 | beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity(GO:0008457) lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity(GO:0047256) |
| 0.6 | 2.5 | GO:0003978 | UDP-N-acetylglucosamine 4-epimerase activity(GO:0003974) UDP-glucose 4-epimerase activity(GO:0003978) |
| 0.6 | 6.2 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
| 0.6 | 2.4 | GO:0070643 | vitamin D3 25-hydroxylase activity(GO:0030343) vitamin D 25-hydroxylase activity(GO:0070643) |
| 0.6 | 3.6 | GO:0005298 | proline:sodium symporter activity(GO:0005298) |
| 0.6 | 2.2 | GO:0050211 | procollagen galactosyltransferase activity(GO:0050211) |
| 0.5 | 1.6 | GO:0001596 | angiotensin type I receptor activity(GO:0001596) |
| 0.5 | 6.5 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
| 0.5 | 1.1 | GO:0047086 | phenanthrene 9,10-monooxygenase activity(GO:0018636) ketosteroid monooxygenase activity(GO:0047086) |
| 0.5 | 2.1 | GO:0004853 | uroporphyrinogen decarboxylase activity(GO:0004853) |
| 0.5 | 2.1 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
| 0.5 | 2.6 | GO:0044736 | acid-sensing ion channel activity(GO:0044736) |
| 0.5 | 2.0 | GO:0004001 | adenosine kinase activity(GO:0004001) |
| 0.5 | 1.4 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
| 0.5 | 2.9 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
| 0.5 | 2.8 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
| 0.5 | 1.4 | GO:0008859 | exoribonuclease II activity(GO:0008859) |
| 0.5 | 1.9 | GO:1902122 | chenodeoxycholic acid binding(GO:1902122) |
| 0.5 | 4.7 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
| 0.5 | 2.3 | GO:0016404 | 15-hydroxyprostaglandin dehydrogenase (NAD+) activity(GO:0016404) |
| 0.5 | 1.9 | GO:0016532 | superoxide dismutase copper chaperone activity(GO:0016532) |
| 0.5 | 2.3 | GO:0004161 | dimethylallyltranstransferase activity(GO:0004161) geranyltranstransferase activity(GO:0004337) |
| 0.5 | 5.9 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) |
| 0.4 | 1.3 | GO:0004618 | phosphoglycerate kinase activity(GO:0004618) |
| 0.4 | 1.3 | GO:0000248 | C-5 sterol desaturase activity(GO:0000248) sterol desaturase activity(GO:0070704) |
| 0.4 | 1.8 | GO:0050119 | N-acetylglucosamine deacetylase activity(GO:0050119) |
| 0.4 | 1.3 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
| 0.4 | 9.1 | GO:0051400 | BH domain binding(GO:0051400) |
| 0.4 | 3.5 | GO:0050815 | phosphoserine binding(GO:0050815) phosphothreonine binding(GO:0050816) |
| 0.4 | 3.3 | GO:0070892 | lipoteichoic acid receptor activity(GO:0070892) |
| 0.4 | 2.0 | GO:0043515 | kinetochore binding(GO:0043515) |
| 0.4 | 1.6 | GO:0045569 | TRAIL binding(GO:0045569) |
| 0.4 | 1.2 | GO:0052857 | NADHX epimerase activity(GO:0052856) NADPHX epimerase activity(GO:0052857) |
| 0.4 | 3.9 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
| 0.4 | 1.2 | GO:0052871 | tocopherol omega-hydroxylase activity(GO:0052870) alpha-tocopherol omega-hydroxylase activity(GO:0052871) 20-hydroxy-leukotriene B4 omega oxidase activity(GO:0097258) 20-aldehyde-leukotriene B4 20-monooxygenase activity(GO:0097259) |
| 0.4 | 1.1 | GO:0052815 | medium-chain acyl-CoA hydrolase activity(GO:0052815) long-chain acyl-CoA hydrolase activity(GO:0052816) |
| 0.4 | 1.1 | GO:0004531 | deoxyribonuclease II activity(GO:0004531) |
| 0.4 | 3.7 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
| 0.4 | 2.2 | GO:0045029 | UDP-activated nucleotide receptor activity(GO:0045029) |
| 0.4 | 5.4 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
| 0.4 | 1.1 | GO:0004912 | interleukin-3 receptor activity(GO:0004912) interleukin-5 receptor activity(GO:0004914) |
| 0.3 | 7.0 | GO:0031994 | insulin-like growth factor I binding(GO:0031994) |
| 0.3 | 5.2 | GO:1901567 | icosanoid binding(GO:0050542) fatty acid derivative binding(GO:1901567) |
| 0.3 | 1.4 | GO:0030107 | HLA-A specific inhibitory MHC class I receptor activity(GO:0030107) |
| 0.3 | 8.6 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
| 0.3 | 0.3 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
| 0.3 | 3.4 | GO:0004969 | histamine receptor activity(GO:0004969) |
| 0.3 | 2.7 | GO:0030613 | oxidoreductase activity, acting on phosphorus or arsenic in donors(GO:0030613) oxidoreductase activity, acting on phosphorus or arsenic in donors, disulfide as acceptor(GO:0030614) |
| 0.3 | 2.0 | GO:0016807 | cysteine-type carboxypeptidase activity(GO:0016807) cysteine-type exopeptidase activity(GO:0070004) |
| 0.3 | 15.8 | GO:0051183 | vitamin transporter activity(GO:0051183) |
| 0.3 | 1.0 | GO:0050613 | delta14-sterol reductase activity(GO:0050613) |
| 0.3 | 10.0 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
| 0.3 | 2.2 | GO:0042289 | MHC class II protein binding(GO:0042289) |
| 0.3 | 1.3 | GO:0017159 | pantetheine hydrolase activity(GO:0017159) |
| 0.3 | 1.3 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
| 0.3 | 2.8 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) ubiquitin-protein transferase activator activity(GO:0097027) |
| 0.3 | 3.1 | GO:0071253 | connexin binding(GO:0071253) |
| 0.3 | 3.4 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
| 0.3 | 5.8 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
| 0.3 | 0.6 | GO:0047661 | racemase and epimerase activity, acting on amino acids and derivatives(GO:0016855) racemase activity, acting on amino acids and derivatives(GO:0036361) amino-acid racemase activity(GO:0047661) |
| 0.3 | 1.5 | GO:0004370 | glycerol kinase activity(GO:0004370) |
| 0.3 | 1.2 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
| 0.3 | 96.0 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
| 0.3 | 4.7 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
| 0.3 | 2.8 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
| 0.3 | 1.1 | GO:0047291 | neolactotetraosylceramide alpha-2,3-sialyltransferase activity(GO:0004513) lactosylceramide alpha-2,3-sialyltransferase activity(GO:0047291) |
| 0.3 | 5.4 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
| 0.3 | 7.9 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
| 0.3 | 2.0 | GO:0043141 | ATP-dependent 5'-3' DNA helicase activity(GO:0043141) |
| 0.3 | 2.5 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
| 0.3 | 2.5 | GO:0060002 | plus-end directed microfilament motor activity(GO:0060002) |
| 0.3 | 2.7 | GO:0032190 | acrosin binding(GO:0032190) |
| 0.3 | 1.1 | GO:0004461 | lactose synthase activity(GO:0004461) |
| 0.3 | 0.8 | GO:0016155 | formyltetrahydrofolate dehydrogenase activity(GO:0016155) |
| 0.3 | 3.1 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
| 0.3 | 1.0 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
| 0.3 | 0.8 | GO:0061609 | fructose-1-phosphate aldolase activity(GO:0061609) |
| 0.2 | 2.7 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
| 0.2 | 1.7 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
| 0.2 | 0.7 | GO:0010698 | acetyltransferase activator activity(GO:0010698) |
| 0.2 | 1.2 | GO:0001010 | transcription factor activity, sequence-specific DNA binding transcription factor recruiting(GO:0001010) |
| 0.2 | 1.4 | GO:0004310 | farnesyl-diphosphate farnesyltransferase activity(GO:0004310) squalene synthase activity(GO:0051996) |
| 0.2 | 0.7 | GO:0003692 | left-handed Z-DNA binding(GO:0003692) |
| 0.2 | 0.7 | GO:0016608 | growth hormone-releasing hormone activity(GO:0016608) |
| 0.2 | 1.2 | GO:0031728 | CCR3 chemokine receptor binding(GO:0031728) |
| 0.2 | 10.3 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
| 0.2 | 1.3 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
| 0.2 | 0.7 | GO:0035605 | peptidyl-cysteine S-nitrosylase activity(GO:0035605) |
| 0.2 | 2.4 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
| 0.2 | 1.3 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
| 0.2 | 1.1 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
| 0.2 | 1.1 | GO:0080019 | fatty-acyl-CoA reductase (alcohol-forming) activity(GO:0080019) |
| 0.2 | 0.9 | GO:0047888 | fatty acid peroxidase activity(GO:0047888) |
| 0.2 | 2.1 | GO:0004321 | fatty-acyl-CoA synthase activity(GO:0004321) |
| 0.2 | 6.6 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
| 0.2 | 0.8 | GO:0052794 | exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
| 0.2 | 6.1 | GO:0005549 | odorant binding(GO:0005549) |
| 0.2 | 0.8 | GO:0004609 | phosphatidylserine decarboxylase activity(GO:0004609) |
| 0.2 | 1.0 | GO:0004105 | choline-phosphate cytidylyltransferase activity(GO:0004105) |
| 0.2 | 1.7 | GO:0086083 | cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication(GO:0086083) |
| 0.2 | 0.8 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
| 0.2 | 1.4 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
| 0.2 | 0.8 | GO:0004088 | carbamoyl-phosphate synthase (ammonia) activity(GO:0004087) carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity(GO:0004088) |
| 0.2 | 1.6 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
| 0.2 | 1.0 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
| 0.2 | 1.0 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
| 0.2 | 0.6 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
| 0.2 | 0.7 | GO:0004991 | parathyroid hormone receptor activity(GO:0004991) |
| 0.2 | 0.7 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
| 0.2 | 0.5 | GO:0004577 | N-acetylglucosaminyldiphosphodolichol N-acetylglucosaminyltransferase activity(GO:0004577) |
| 0.2 | 1.6 | GO:0099580 | ion antiporter activity involved in regulation of postsynaptic membrane potential(GO:0099580) |
| 0.2 | 5.0 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
| 0.2 | 0.9 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
| 0.2 | 1.4 | GO:0008269 | JAK pathway signal transduction adaptor activity(GO:0008269) |
| 0.2 | 0.5 | GO:0071885 | N-terminal protein N-methyltransferase activity(GO:0071885) |
| 0.2 | 3.0 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
| 0.2 | 0.9 | GO:0023024 | MHC class I protein complex binding(GO:0023024) |
| 0.2 | 2.1 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
| 0.2 | 1.5 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
| 0.2 | 0.5 | GO:0004421 | hydroxymethylglutaryl-CoA synthase activity(GO:0004421) |
| 0.2 | 4.8 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
| 0.2 | 3.3 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
| 0.2 | 2.0 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
| 0.2 | 5.5 | GO:0031628 | opioid receptor binding(GO:0031628) |
| 0.2 | 3.3 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
| 0.2 | 0.8 | GO:0004473 | malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) malate dehydrogenase (decarboxylating) (NADP+) activity(GO:0004473) |
| 0.2 | 1.0 | GO:0035243 | protein-arginine omega-N symmetric methyltransferase activity(GO:0035243) |
| 0.2 | 2.4 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
| 0.2 | 3.0 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
| 0.2 | 1.4 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
| 0.2 | 0.2 | GO:0045295 | gamma-catenin binding(GO:0045295) |
| 0.2 | 1.2 | GO:0004996 | thyroid-stimulating hormone receptor activity(GO:0004996) |
| 0.2 | 0.9 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
| 0.2 | 2.2 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
| 0.2 | 4.4 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
| 0.2 | 1.4 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
| 0.1 | 0.9 | GO:0005353 | fructose transmembrane transporter activity(GO:0005353) |
| 0.1 | 1.3 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
| 0.1 | 5.6 | GO:0008028 | monocarboxylic acid transmembrane transporter activity(GO:0008028) |
| 0.1 | 0.7 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
| 0.1 | 1.7 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
| 0.1 | 0.8 | GO:0035800 | deubiquitinase activator activity(GO:0035800) |
| 0.1 | 0.8 | GO:0060961 | phospholipase D inhibitor activity(GO:0060961) |
| 0.1 | 3.0 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
| 0.1 | 1.8 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
| 0.1 | 0.9 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
| 0.1 | 0.9 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
| 0.1 | 5.1 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
| 0.1 | 1.1 | GO:0046870 | cadmium ion binding(GO:0046870) |
| 0.1 | 0.7 | GO:0003875 | ADP-ribosylarginine hydrolase activity(GO:0003875) |
| 0.1 | 1.5 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) activin binding(GO:0048185) |
| 0.1 | 0.3 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
| 0.1 | 5.2 | GO:0004622 | lysophospholipase activity(GO:0004622) |
| 0.1 | 8.9 | GO:0008307 | structural constituent of muscle(GO:0008307) |
| 0.1 | 2.6 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
| 0.1 | 0.6 | GO:0004882 | androgen receptor activity(GO:0004882) |
| 0.1 | 0.5 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
| 0.1 | 1.7 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
| 0.1 | 1.3 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
| 0.1 | 1.4 | GO:0030284 | estrogen receptor activity(GO:0030284) |
| 0.1 | 0.6 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
| 0.1 | 0.6 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
| 0.1 | 3.4 | GO:0005523 | tropomyosin binding(GO:0005523) |
| 0.1 | 1.2 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
| 0.1 | 0.3 | GO:0004651 | polynucleotide 5'-phosphatase activity(GO:0004651) |
| 0.1 | 1.1 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
| 0.1 | 1.1 | GO:0048406 | nerve growth factor binding(GO:0048406) |
| 0.1 | 1.1 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
| 0.1 | 2.1 | GO:0043422 | protein kinase B binding(GO:0043422) |
| 0.1 | 1.5 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
| 0.1 | 0.8 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
| 0.1 | 1.0 | GO:0099583 | neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration(GO:0099583) |
| 0.1 | 0.6 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
| 0.1 | 1.7 | GO:0015385 | sodium:proton antiporter activity(GO:0015385) |
| 0.1 | 3.3 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
| 0.1 | 0.6 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
| 0.1 | 1.6 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
| 0.1 | 1.3 | GO:0005436 | sodium:phosphate symporter activity(GO:0005436) |
| 0.1 | 0.5 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
| 0.1 | 4.8 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
| 0.1 | 1.7 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
| 0.1 | 2.8 | GO:0031489 | myosin V binding(GO:0031489) |
| 0.1 | 0.6 | GO:0031748 | D1 dopamine receptor binding(GO:0031748) |
| 0.1 | 1.9 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
| 0.1 | 2.1 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
| 0.1 | 2.8 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
| 0.1 | 2.5 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
| 0.1 | 4.3 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
| 0.1 | 1.7 | GO:0042834 | peptidoglycan binding(GO:0042834) |
| 0.1 | 3.6 | GO:0005504 | fatty acid binding(GO:0005504) |
| 0.1 | 0.5 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
| 0.1 | 0.8 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
| 0.1 | 0.2 | GO:0080130 | L-phenylalanine:2-oxoglutarate aminotransferase activity(GO:0080130) |
| 0.1 | 0.4 | GO:0001026 | TFIIIB-type transcription factor activity(GO:0001026) |
| 0.1 | 2.0 | GO:0051393 | alpha-actinin binding(GO:0051393) |
| 0.1 | 4.9 | GO:0005080 | protein kinase C binding(GO:0005080) |
| 0.1 | 0.3 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
| 0.1 | 1.1 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) |
| 0.1 | 0.5 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
| 0.1 | 0.5 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
| 0.1 | 15.6 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
| 0.1 | 2.7 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
| 0.1 | 0.3 | GO:0004117 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) |
| 0.1 | 0.3 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
| 0.1 | 2.8 | GO:0070182 | DNA polymerase binding(GO:0070182) |
| 0.1 | 0.9 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
| 0.1 | 6.9 | GO:0043621 | protein self-association(GO:0043621) |
| 0.1 | 2.2 | GO:0017160 | Ral GTPase binding(GO:0017160) |
| 0.1 | 0.6 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
| 0.1 | 0.4 | GO:0008453 | alanine-glyoxylate transaminase activity(GO:0008453) |
| 0.1 | 0.6 | GO:0038064 | collagen receptor activity(GO:0038064) |
| 0.1 | 0.6 | GO:0005047 | signal recognition particle binding(GO:0005047) |
| 0.1 | 4.4 | GO:0050699 | WW domain binding(GO:0050699) |
| 0.1 | 6.4 | GO:1990782 | protein tyrosine kinase binding(GO:1990782) |
| 0.1 | 0.8 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
| 0.1 | 5.8 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
| 0.1 | 0.6 | GO:0022897 | peptide:proton symporter activity(GO:0015333) proton-dependent peptide secondary active transmembrane transporter activity(GO:0022897) |
| 0.1 | 0.5 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
| 0.1 | 0.4 | GO:0016936 | galactoside binding(GO:0016936) |
| 0.1 | 0.6 | GO:0008079 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
| 0.1 | 0.6 | GO:0010340 | carboxyl-O-methyltransferase activity(GO:0010340) protein carboxyl O-methyltransferase activity(GO:0051998) |
| 0.1 | 0.9 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
| 0.1 | 0.3 | GO:0070139 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
| 0.1 | 0.9 | GO:0004526 | ribonuclease P activity(GO:0004526) |
| 0.1 | 0.9 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
| 0.1 | 0.8 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
| 0.1 | 0.4 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
| 0.1 | 0.4 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
| 0.1 | 0.2 | GO:0005017 | platelet-derived growth factor-activated receptor activity(GO:0005017) |
| 0.1 | 1.2 | GO:0005243 | gap junction channel activity(GO:0005243) |
| 0.1 | 1.3 | GO:0070001 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
| 0.1 | 0.5 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
| 0.1 | 0.1 | GO:0033265 | choline binding(GO:0033265) |
| 0.1 | 2.3 | GO:0019956 | chemokine binding(GO:0019956) |
| 0.1 | 1.2 | GO:0016918 | retinal binding(GO:0016918) |
| 0.1 | 0.6 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
| 0.1 | 0.6 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
| 0.1 | 0.5 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
| 0.1 | 8.0 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
| 0.1 | 0.4 | GO:0017060 | 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity(GO:0017060) |
| 0.1 | 1.8 | GO:0008242 | omega peptidase activity(GO:0008242) |
| 0.1 | 0.2 | GO:0004608 | phosphatidyl-N-methylethanolamine N-methyltransferase activity(GO:0000773) phosphatidylethanolamine N-methyltransferase activity(GO:0004608) phosphatidyl-N-dimethylethanolamine N-methyltransferase activity(GO:0080101) |
| 0.1 | 0.3 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
| 0.1 | 0.3 | GO:0099609 | microtubule lateral binding(GO:0099609) |
| 0.1 | 10.2 | GO:0008201 | heparin binding(GO:0008201) |
| 0.1 | 0.3 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
| 0.1 | 0.5 | GO:0030492 | hemoglobin binding(GO:0030492) |
| 0.1 | 0.6 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
| 0.1 | 0.7 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
| 0.1 | 4.3 | GO:0097110 | scaffold protein binding(GO:0097110) |
| 0.1 | 1.0 | GO:0001134 | transcription factor activity, transcription factor recruiting(GO:0001134) |
| 0.1 | 0.5 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
| 0.1 | 0.2 | GO:0004963 | follicle-stimulating hormone receptor activity(GO:0004963) |
| 0.1 | 2.4 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
| 0.1 | 0.8 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
| 0.1 | 2.2 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
| 0.1 | 0.2 | GO:0008506 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
| 0.1 | 0.2 | GO:0017129 | triglyceride binding(GO:0017129) |
| 0.1 | 0.2 | GO:0052812 | phosphatidylinositol-3,4-bisphosphate 5-kinase activity(GO:0052812) |
| 0.1 | 0.2 | GO:0047237 | glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047237) |
| 0.1 | 1.2 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
| 0.1 | 3.5 | GO:0017171 | serine hydrolase activity(GO:0017171) |
| 0.1 | 0.5 | GO:0042608 | T cell receptor binding(GO:0042608) |
| 0.1 | 0.2 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
| 0.1 | 1.1 | GO:0005522 | profilin binding(GO:0005522) |
| 0.1 | 0.6 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
| 0.1 | 5.1 | GO:0005518 | collagen binding(GO:0005518) |
| 0.1 | 0.5 | GO:0036122 | BMP binding(GO:0036122) |
| 0.1 | 0.2 | GO:0032093 | SAM domain binding(GO:0032093) |
| 0.1 | 0.3 | GO:0015265 | urea channel activity(GO:0015265) |
| 0.1 | 1.5 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
| 0.1 | 0.3 | GO:0035614 | snRNA stem-loop binding(GO:0035614) |
| 0.1 | 0.2 | GO:0051538 | succinate dehydrogenase (ubiquinone) activity(GO:0008177) 3 iron, 4 sulfur cluster binding(GO:0051538) |
| 0.1 | 0.6 | GO:0001042 | RNA polymerase I core binding(GO:0001042) |
| 0.1 | 1.5 | GO:0070840 | dynein complex binding(GO:0070840) |
| 0.1 | 0.2 | GO:0070051 | fibrinogen binding(GO:0070051) |
| 0.1 | 0.1 | GO:0000035 | acyl binding(GO:0000035) |
| 0.1 | 1.5 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
| 0.1 | 0.4 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
| 0.1 | 0.4 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
| 0.1 | 0.8 | GO:1901612 | phosphatidylglycerol binding(GO:1901611) cardiolipin binding(GO:1901612) |
| 0.1 | 0.4 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
| 0.1 | 15.1 | GO:0008017 | microtubule binding(GO:0008017) |
| 0.1 | 0.2 | GO:0042947 | glucoside transmembrane transporter activity(GO:0042947) |
| 0.1 | 0.6 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
| 0.1 | 4.8 | GO:0001618 | virus receptor activity(GO:0001618) |
| 0.0 | 0.2 | GO:0004357 | glutamate-cysteine ligase activity(GO:0004357) |
| 0.0 | 0.3 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
| 0.0 | 0.6 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
| 0.0 | 0.7 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
| 0.0 | 0.6 | GO:0031386 | protein tag(GO:0031386) |
| 0.0 | 0.2 | GO:0047179 | platelet-activating factor acetyltransferase activity(GO:0047179) |
| 0.0 | 0.2 | GO:0003943 | N-acetylgalactosamine-4-sulfatase activity(GO:0003943) |
| 0.0 | 0.5 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
| 0.0 | 0.7 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
| 0.0 | 2.6 | GO:0030145 | manganese ion binding(GO:0030145) |
| 0.0 | 0.7 | GO:0048018 | receptor agonist activity(GO:0048018) |
| 0.0 | 0.5 | GO:0004950 | G-protein coupled chemoattractant receptor activity(GO:0001637) chemokine receptor activity(GO:0004950) |
| 0.0 | 2.0 | GO:0045182 | translation regulator activity(GO:0045182) |
| 0.0 | 1.4 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
| 0.0 | 1.2 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
| 0.0 | 0.3 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
| 0.0 | 1.6 | GO:0008187 | poly-pyrimidine tract binding(GO:0008187) |
| 0.0 | 0.3 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
| 0.0 | 0.6 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
| 0.0 | 0.5 | GO:0097602 | cullin family protein binding(GO:0097602) |
| 0.0 | 0.1 | GO:0008480 | sarcosine dehydrogenase activity(GO:0008480) |
| 0.0 | 1.3 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
| 0.0 | 0.2 | GO:0004530 | deoxyribonuclease I activity(GO:0004530) |
| 0.0 | 0.2 | GO:0003963 | RNA-3'-phosphate cyclase activity(GO:0003963) |
| 0.0 | 0.6 | GO:0019864 | IgG binding(GO:0019864) |
| 0.0 | 0.4 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
| 0.0 | 0.5 | GO:0070324 | thyroid hormone binding(GO:0070324) |
| 0.0 | 0.1 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
| 0.0 | 0.3 | GO:0036310 | annealing helicase activity(GO:0036310) |
| 0.0 | 0.1 | GO:0004419 | hydroxymethylglutaryl-CoA lyase activity(GO:0004419) |
| 0.0 | 0.2 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
| 0.0 | 0.1 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
| 0.0 | 1.7 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
| 0.0 | 1.1 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
| 0.0 | 0.2 | GO:0015114 | phosphate ion transmembrane transporter activity(GO:0015114) |
| 0.0 | 4.1 | GO:0008013 | beta-catenin binding(GO:0008013) |
| 0.0 | 0.2 | GO:1990460 | leptin receptor binding(GO:1990460) |
| 0.0 | 0.6 | GO:0019992 | diacylglycerol binding(GO:0019992) |
| 0.0 | 3.3 | GO:0002039 | p53 binding(GO:0002039) |
| 0.0 | 1.8 | GO:0043022 | ribosome binding(GO:0043022) |
| 0.0 | 0.8 | GO:1905030 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
| 0.0 | 5.6 | GO:0044325 | ion channel binding(GO:0044325) |
| 0.0 | 0.9 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
| 0.0 | 1.5 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
| 0.0 | 0.3 | GO:0004955 | prostaglandin receptor activity(GO:0004955) |
| 0.0 | 0.3 | GO:0098748 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
| 0.0 | 0.5 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
| 0.0 | 0.2 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
| 0.0 | 0.3 | GO:0048156 | tau protein binding(GO:0048156) |
| 0.0 | 1.6 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
| 0.0 | 0.1 | GO:0004487 | methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
| 0.0 | 0.4 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
| 0.0 | 0.6 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
| 0.0 | 0.2 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
| 0.0 | 10.1 | GO:0045296 | cadherin binding(GO:0045296) |
| 0.0 | 0.5 | GO:0008432 | JUN kinase binding(GO:0008432) |
| 0.0 | 0.2 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
| 0.0 | 0.1 | GO:0050262 | ribosylnicotinamide kinase activity(GO:0050262) ribosylnicotinate kinase activity(GO:0061769) |
| 0.0 | 0.2 | GO:0030884 | lipid antigen binding(GO:0030882) endogenous lipid antigen binding(GO:0030883) exogenous lipid antigen binding(GO:0030884) |
| 0.0 | 1.9 | GO:0035064 | methylated histone binding(GO:0035064) |
| 0.0 | 0.8 | GO:0008327 | methyl-CpG binding(GO:0008327) |
| 0.0 | 0.2 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
| 0.0 | 3.6 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
| 0.0 | 0.7 | GO:0043531 | ADP binding(GO:0043531) |
| 0.0 | 0.4 | GO:0004697 | protein kinase C activity(GO:0004697) |
| 0.0 | 0.4 | GO:0005355 | glucose transmembrane transporter activity(GO:0005355) |
| 0.0 | 0.5 | GO:0070410 | co-SMAD binding(GO:0070410) |
| 0.0 | 0.3 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
| 0.0 | 0.7 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
| 0.0 | 0.3 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
| 0.0 | 0.2 | GO:0001164 | RNA polymerase I regulatory region DNA binding(GO:0001013) RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
| 0.0 | 0.5 | GO:0030414 | peptidase inhibitor activity(GO:0030414) |
| 0.0 | 0.2 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
| 0.0 | 0.1 | GO:0016503 | pheromone receptor activity(GO:0016503) |
| 0.0 | 0.6 | GO:0042923 | neuropeptide binding(GO:0042923) |
| 0.0 | 0.4 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
| 0.0 | 0.1 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
| 0.0 | 0.2 | GO:0046790 | virion binding(GO:0046790) |
| 0.0 | 0.3 | GO:0003680 | AT DNA binding(GO:0003680) |
| 0.0 | 0.2 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
| 0.0 | 0.1 | GO:0004771 | sterol esterase activity(GO:0004771) |
| 0.0 | 1.5 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
| 0.0 | 0.1 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
| 0.0 | 0.9 | GO:0015485 | cholesterol binding(GO:0015485) |
| 0.0 | 0.1 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
| 0.0 | 0.3 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) |
| 0.0 | 6.3 | GO:0005525 | GTP binding(GO:0005525) |
| 0.0 | 0.5 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
| 0.0 | 0.5 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
| 0.0 | 0.1 | GO:0051120 | hepoxilin A3 synthase activity(GO:0051120) |
| 0.0 | 0.1 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
| 0.0 | 0.0 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
| 0.0 | 2.1 | GO:0030674 | protein binding, bridging(GO:0030674) |
| 0.0 | 0.3 | GO:0047617 | acyl-CoA hydrolase activity(GO:0047617) |
| 0.0 | 0.3 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
| 0.0 | 0.5 | GO:0031491 | nucleosome binding(GO:0031491) |
| 0.0 | 0.5 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
| 0.0 | 0.1 | GO:0070492 | oligosaccharide binding(GO:0070492) |
| 0.0 | 0.8 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
| 0.0 | 1.2 | GO:0005178 | integrin binding(GO:0005178) |
| 0.0 | 0.2 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
| 0.0 | 0.1 | GO:0008097 | 5S rRNA binding(GO:0008097) |
| 0.0 | 0.1 | GO:0050294 | steroid sulfotransferase activity(GO:0050294) |
| 0.0 | 0.3 | GO:0030552 | cAMP binding(GO:0030552) |
| 0.0 | 0.3 | GO:0038191 | neuropilin binding(GO:0038191) |
| 0.0 | 0.1 | GO:0034235 | GPI anchor binding(GO:0034235) |
| 0.0 | 0.2 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
| 0.0 | 0.6 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) |
| 0.0 | 1.4 | GO:0004984 | olfactory receptor activity(GO:0004984) |
| 0.0 | 0.2 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
| 0.0 | 0.1 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
Gene overrepresentation in curated gene sets: canonical pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.1 | 20.2 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
| 0.4 | 16.2 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
| 0.3 | 21.3 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
| 0.3 | 2.1 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
| 0.3 | 9.7 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
| 0.2 | 8.7 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
| 0.2 | 3.1 | ST STAT3 PATHWAY | STAT3 Pathway |
| 0.2 | 13.4 | PID AURORA B PATHWAY | Aurora B signaling |
| 0.2 | 5.6 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
| 0.2 | 83.8 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
| 0.2 | 61.3 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
| 0.2 | 6.4 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
| 0.2 | 9.5 | PID RHOA PATHWAY | RhoA signaling pathway |
| 0.2 | 10.6 | PID PLK1 PATHWAY | PLK1 signaling events |
| 0.2 | 1.8 | PID IL5 PATHWAY | IL5-mediated signaling events |
| 0.1 | 1.0 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
| 0.1 | 37.0 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
| 0.1 | 2.2 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
| 0.1 | 0.5 | PID IL12 2PATHWAY | IL12-mediated signaling events |
| 0.1 | 11.1 | PID BCR 5PATHWAY | BCR signaling pathway |
| 0.1 | 1.4 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
| 0.1 | 1.5 | PID ALK2 PATHWAY | ALK2 signaling events |
| 0.1 | 1.4 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
| 0.1 | 0.6 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
| 0.1 | 4.6 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
| 0.1 | 0.4 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
| 0.1 | 2.0 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
| 0.1 | 3.7 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
| 0.1 | 2.2 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
| 0.1 | 4.3 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
| 0.1 | 2.3 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
| 0.1 | 1.6 | PID TRAIL PATHWAY | TRAIL signaling pathway |
| 0.1 | 1.1 | PID IL27 PATHWAY | IL27-mediated signaling events |
| 0.1 | 1.7 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
| 0.1 | 1.0 | PID ATR PATHWAY | ATR signaling pathway |
| 0.1 | 3.1 | PID TNF PATHWAY | TNF receptor signaling pathway |
| 0.1 | 0.6 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
| 0.1 | 4.4 | NABA COLLAGENS | Genes encoding collagen proteins |
| 0.1 | 2.5 | PID EPHA FWDPATHWAY | EPHA forward signaling |
| 0.1 | 1.7 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
| 0.1 | 4.2 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
| 0.1 | 2.4 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
| 0.1 | 1.8 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
| 0.1 | 1.3 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
| 0.1 | 1.4 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
| 0.1 | 1.2 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
| 0.1 | 1.7 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
| 0.1 | 0.2 | PID S1P S1P1 PATHWAY | S1P1 pathway |
| 0.1 | 1.1 | PID IL2 1PATHWAY | IL2-mediated signaling events |
| 0.1 | 0.3 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
| 0.1 | 1.0 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
| 0.1 | 1.7 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
| 0.0 | 1.9 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
| 0.0 | 1.5 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
| 0.0 | 2.1 | PID FANCONI PATHWAY | Fanconi anemia pathway |
| 0.0 | 3.0 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
| 0.0 | 0.7 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
| 0.0 | 0.8 | PID REELIN PATHWAY | Reelin signaling pathway |
| 0.0 | 0.7 | ST G ALPHA S PATHWAY | G alpha s Pathway |
| 0.0 | 0.5 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
| 0.0 | 0.7 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
| 0.0 | 1.5 | PID ILK PATHWAY | Integrin-linked kinase signaling |
| 0.0 | 3.1 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
| 0.0 | 0.3 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
| 0.0 | 2.1 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
| 0.0 | 1.0 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
| 0.0 | 0.4 | PID AURORA A PATHWAY | Aurora A signaling |
| 0.0 | 0.4 | PID FOXO PATHWAY | FoxO family signaling |
| 0.0 | 0.2 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
| 0.0 | 1.0 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
| 0.0 | 0.3 | PID EPHB FWD PATHWAY | EPHB forward signaling |
| 0.0 | 0.3 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
| 0.0 | 0.6 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
| 0.0 | 1.1 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
| 0.0 | 0.4 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
| 0.0 | 1.3 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
| 0.0 | 1.0 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
| 0.0 | 0.2 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
| 0.0 | 0.6 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
| 0.0 | 0.6 | PID ERBB4 PATHWAY | ErbB4 signaling events |
| 0.0 | 0.2 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
| 0.0 | 0.1 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
| 0.0 | 1.2 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
| 0.0 | 0.4 | PID ARF 3PATHWAY | Arf1 pathway |
| 0.0 | 0.2 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
| 0.0 | 0.3 | PID ATM PATHWAY | ATM pathway |
| 0.0 | 0.4 | PID MYC PATHWAY | C-MYC pathway |
| 0.0 | 0.8 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
| 0.0 | 0.2 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
| 0.0 | 0.6 | PID LKB1 PATHWAY | LKB1 signaling events |
| 0.0 | 0.3 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
| 0.0 | 0.1 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
| 0.0 | 0.8 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
Gene overrepresentation in curated gene sets: REACTOME pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.8 | 31.2 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
| 0.7 | 13.1 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
| 0.5 | 5.9 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
| 0.4 | 9.1 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
| 0.4 | 8.0 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
| 0.4 | 1.1 | REACTOME REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN | Genes involved in Regulation of Glucokinase by Glucokinase Regulatory Protein |
| 0.3 | 6.4 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
| 0.3 | 4.9 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
| 0.3 | 9.7 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
| 0.3 | 7.7 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
| 0.3 | 6.1 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
| 0.3 | 17.7 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
| 0.3 | 5.8 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
| 0.3 | 8.5 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
| 0.2 | 5.1 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
| 0.2 | 8.9 | REACTOME KINESINS | Genes involved in Kinesins |
| 0.2 | 8.1 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
| 0.2 | 9.4 | REACTOME TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS | Genes involved in TGF-beta receptor signaling activates SMADs |
| 0.2 | 2.3 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
| 0.2 | 6.3 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
| 0.2 | 3.3 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
| 0.2 | 4.1 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
| 0.2 | 3.1 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
| 0.2 | 1.7 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
| 0.2 | 2.0 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
| 0.1 | 2.5 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
| 0.1 | 1.4 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
| 0.1 | 1.8 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
| 0.1 | 2.4 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
| 0.1 | 2.4 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
| 0.1 | 1.4 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
| 0.1 | 3.0 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
| 0.1 | 13.2 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
| 0.1 | 2.8 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
| 0.1 | 3.3 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
| 0.1 | 5.3 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
| 0.1 | 3.1 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
| 0.1 | 5.0 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
| 0.1 | 0.9 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
| 0.1 | 2.5 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
| 0.1 | 1.8 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
| 0.1 | 19.6 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
| 0.1 | 0.7 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
| 0.1 | 3.1 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
| 0.1 | 4.1 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
| 0.1 | 1.6 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
| 0.1 | 5.9 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
| 0.1 | 4.9 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
| 0.1 | 2.2 | REACTOME FGFR1 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR1 ligand binding and activation |
| 0.1 | 3.2 | REACTOME AMYLOIDS | Genes involved in Amyloids |
| 0.1 | 0.6 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
| 0.1 | 1.4 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
| 0.1 | 1.6 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
| 0.1 | 0.8 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
| 0.1 | 11.4 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
| 0.1 | 3.4 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
| 0.1 | 1.4 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
| 0.1 | 6.5 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
| 0.1 | 2.2 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
| 0.1 | 1.1 | REACTOME OPSINS | Genes involved in Opsins |
| 0.1 | 1.0 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
| 0.1 | 1.0 | REACTOME ACTIVATION OF THE PRE REPLICATIVE COMPLEX | Genes involved in Activation of the pre-replicative complex |
| 0.1 | 5.4 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
| 0.1 | 1.8 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
| 0.1 | 1.1 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
| 0.1 | 1.7 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
| 0.1 | 1.6 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
| 0.1 | 1.3 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
| 0.1 | 3.5 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
| 0.1 | 1.1 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
| 0.1 | 1.7 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
| 0.1 | 0.8 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
| 0.1 | 3.2 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
| 0.1 | 1.9 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
| 0.1 | 6.2 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS | Genes involved in APC/C:Cdc20 mediated degradation of mitotic proteins |
| 0.1 | 0.5 | REACTOME PROCESSIVE SYNTHESIS ON THE LAGGING STRAND | Genes involved in Processive synthesis on the lagging strand |
| 0.1 | 0.9 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
| 0.1 | 1.6 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
| 0.1 | 2.2 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
| 0.1 | 7.7 | REACTOME G ALPHA Q SIGNALLING EVENTS | Genes involved in G alpha (q) signalling events |
| 0.1 | 2.8 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
| 0.1 | 0.6 | REACTOME G PROTEIN BETA GAMMA SIGNALLING | Genes involved in G-protein beta:gamma signalling |
| 0.1 | 1.0 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
| 0.1 | 1.1 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
| 0.1 | 1.5 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
| 0.1 | 1.2 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
| 0.0 | 0.2 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
| 0.0 | 1.1 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
| 0.0 | 1.2 | REACTOME ACYL CHAIN REMODELLING OF PE | Genes involved in Acyl chain remodelling of PE |
| 0.0 | 1.0 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
| 0.0 | 0.5 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
| 0.0 | 0.8 | REACTOME SIGNALING BY FGFR1 MUTANTS | Genes involved in Signaling by FGFR1 mutants |
| 0.0 | 9.7 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
| 0.0 | 1.8 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
| 0.0 | 2.6 | REACTOME RIG I MDA5 MEDIATED INDUCTION OF IFN ALPHA BETA PATHWAYS | Genes involved in RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways |
| 0.0 | 6.3 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
| 0.0 | 2.5 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
| 0.0 | 0.2 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
| 0.0 | 1.6 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
| 0.0 | 1.4 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
| 0.0 | 0.5 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
| 0.0 | 0.3 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
| 0.0 | 4.2 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
| 0.0 | 0.5 | REACTOME PURINE METABOLISM | Genes involved in Purine metabolism |
| 0.0 | 0.9 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
| 0.0 | 0.2 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
| 0.0 | 0.8 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
| 0.0 | 1.8 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
| 0.0 | 1.1 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
| 0.0 | 0.5 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
| 0.0 | 1.1 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
| 0.0 | 1.8 | REACTOME ASPARAGINE N LINKED GLYCOSYLATION | Genes involved in Asparagine N-linked glycosylation |
| 0.0 | 0.3 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
| 0.0 | 0.9 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
| 0.0 | 1.5 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
| 0.0 | 0.5 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
| 0.0 | 0.3 | REACTOME DOUBLE STRAND BREAK REPAIR | Genes involved in Double-Strand Break Repair |
| 0.0 | 1.4 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
| 0.0 | 1.5 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
| 0.0 | 0.4 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
| 0.0 | 0.2 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
| 0.0 | 0.4 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
| 0.0 | 0.2 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
| 0.0 | 0.6 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
| 0.0 | 0.6 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
| 0.0 | 0.3 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
| 0.0 | 0.2 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
| 0.0 | 0.2 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
| 0.0 | 0.7 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
| 0.0 | 0.6 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
| 0.0 | 0.6 | REACTOME DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR | Genes involved in Downstream Signaling Events Of B Cell Receptor (BCR) |
| 0.0 | 0.6 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
| 0.0 | 0.5 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
| 0.0 | 1.0 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
| 0.0 | 1.0 | REACTOME RECRUITMENT OF MITOTIC CENTROSOME PROTEINS AND COMPLEXES | Genes involved in Recruitment of mitotic centrosome proteins and complexes |
| 0.0 | 0.2 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
| 0.0 | 0.2 | REACTOME ACTIVATION OF KAINATE RECEPTORS UPON GLUTAMATE BINDING | Genes involved in Activation of Kainate Receptors upon glutamate binding |
| 0.0 | 0.4 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
| 0.0 | 0.2 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
| 0.0 | 0.2 | REACTOME NEF MEDIATES DOWN MODULATION OF CELL SURFACE RECEPTORS BY RECRUITING THEM TO CLATHRIN ADAPTERS | Genes involved in Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters |